Connective tissue disorder
MONDO:0003900A disease involving the connective tissue.
Also known as: connective tissue disease, connective tissue disease or disorder, connective tissue diseases, connective tissue disorder, connective tissue disorders, disease of connective tissue, disease or disorder of connective tissue, disease, connective tissue
4647 clinical trials for this condition and its sub-types, 71 tagged with Connective tissue disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Connective tissue disorder
-
Connective tissue neoplasm 1 trial · 2,406 incl. sub-types
13 sub-types
- Bone neoplasm 26 trials · 2,118 incl. sub-types Sub-types →
- Fibroblastic neoplasm 0 trials · 210 incl. sub-types Sub-types →
- Tumor of adipose tissue 1 trial · 98 incl. sub-types Sub-types →
- Chondrosarcoma 39 trials · 44 incl. sub-types Sub-types →
- Tenosynovial giant cell tumor 12 trials · 16 incl. sub-types Sub-types →
- Chondroma 4 trials Sub-types →
- Cholangiolocellular carcinoma 1 trial
- Solitary fibrous tumor/hemangiopericytoma 1 trial
- Angiomyxoma 0 trials
- Cartilage cancer 0 trials
- Dartoic leiomyoma 0 trials
- Lipofibromatosis-like neural tumor 0 trials
- Scirrhous adenocarcinoma 0 trials
-
Rheumatic disorder 91 trials · 1,797 incl. sub-types
30 sub-types
- Rheumatoid arthritis 578 trials · 797 incl. sub-types Sub-types →
- Lupus erythematosus 40 trials · 551 incl. sub-types Sub-types →
- Scleroderma 47 trials · 305 incl. sub-types Sub-types →
- Autoinflammatory syndrome 21 trials · 208 incl. sub-types Sub-types →
- Juvenile idiopathic arthritis 107 trials · 115 incl. sub-types Sub-types →
- Dermatomyositis 81 trials · 100 incl. sub-types Sub-types →
- Polymyalgia rheumatica 30 trials
- Rheumatic fever 17 trials
- Mixed connective tissue disease 15 trials
- Reactive arthritis 6 trials
- Camptodactyly-arthropathy-coxa vara-pericarditis syndrome 4 trials
- Gorham-Stout disease 2 trials
- Sweet syndrome 2 trials
- Palindromic rheumatism 1 trial
- Rheumatic disease of mitral valve 1 trial
- IL10-related early-onset inflammatory bowel disease 0 trials Sub-types →
- LAMA5-related multisystemic syndrome 0 trials
- Reye syndrome 0 trials
- Wissler syndrome 0 trials
- Acroosteolysis dominant type 0 trials
- Chondrocalcinosis 2 0 trials
- Fibroblastic rheumatism 0 trials
- Idiopathic juvenile osteoporosis 0 trials
- Intermittent hydrarthrosis 0 trials
- Interstitial granulomatous dermatitis with arthritis 0 trials
- Isolated sternocostoclavicular hyperostosis 0 trials
- Myalgia-eosinophilia syndrome associated with tryptophan 0 trials
- Progeria-associated arthropathy 0 trials
- Rheumatic pulmonary valve disease 0 trials
- Unexplained long-lasting fever/inflammatory syndrome 0 trials
-
Hereditary disorder of connective tissue 0 trials · 1,314 incl. sub-types
88 sub-types
- Systemic lupus erythematosus 518 trials · 524 incl. sub-types Sub-types →
- Chronic myelogenous leukemia, BCR-ABL1 positive 211 trials · 253 incl. sub-types Sub-types →
- Uterine corpus leiomyoma 104 trials · 109 incl. sub-types Sub-types →
- Acquired polycythemia vera 90 trials
- Chondrosarcoma 39 trials · 44 incl. sub-types Sub-types →
- Type 2 collagenopathy 0 trials · 39 incl. sub-types Sub-types →
- CHILD syndrome 37 trials
- Desmoid tumor 36 trials Sub-types →
- Familial isolated pituitary adenoma 1 trial · 31 incl. sub-types Sub-types →
- Inherited acute myeloid leukemia 1 trial · 25 incl. sub-types Sub-types →
- Hereditary periodic fever syndrome 5 trials · 24 incl. sub-types Sub-types →
- Marfan and Marfan-related disorder 1 trial · 22 incl. sub-types Sub-types →
- VEXAS syndrome 18 trials
- Hypermobility spectrum disorder 17 trials
- Peyronie disease 12 trials
- Aicardi-Goutieres syndrome 9 trials Sub-types →
- Autosomal recessive inherited pseudoxanthoma elasticum 7 trials
- Ewing sarcoma of bone 5 trials
- TREX1-related type 1 interferonopathy 0 trials · 5 incl. sub-types Sub-types →
- Camptodactyly-arthropathy-coxa vara-pericarditis syndrome 4 trials
- Chronic recurrent multifocal osteomyelitis 3 trials · 4 incl. sub-types Sub-types →
- Blau syndrome 3 trials
- Ollier disease 3 trials
- Autoimmune interstitial lung disease-arthritis syndrome 3 trials Sub-types →
- Deficiency of adenosine deaminase 2 3 trials
- Hereditary multiple osteochondromas 3 trials Sub-types →
- Inherited torticollis 3 trials
- Maffucci syndrome 2 trials
- STING-associated vasculopathy with onset in infancy 2 trials
- Familial chilblain lupus 2 trials Sub-types →
- Proteosome-associated autoinflammatory syndrome 2 trials Sub-types →
- Sweet syndrome 2 trials
- ADAR-related type 1 interferonopathy 0 trials · 1 incl. sub-types Sub-types →
- Singleton-Merten dysplasia 1 trial Sub-types →
- Arterial tortuosity syndrome 1 trial
- Cherubism 1 trial Sub-types →
- Hyperparathyroidism 2 with jaw tumors 1 trial
- Infantile myofibromatosis 1 trial Sub-types →
- Neonatal severe primary hyperparathyroidism 1 trial
- Ossification of the posterior longitudinal ligament of the spine 1 trial
- EMILIN-1-related connective tissue disease 0 trials
- Ehlers-Danlos syndrome, kyphoscoliotic type 1 0 trials
- IFIH1-related type 1 interferonopathy 0 trials Sub-types →
- IL10-related early-onset inflammatory bowel disease 0 trials Sub-types →
- LAMA5-related multisystemic syndrome 0 trials
- MASS syndrome 0 trials
- Pelger-Huet-like anomaly and episodic fever with abdominal pain 0 trials
- RNASEH2A-related type 1 interferonopathy 0 trials Sub-types →
- RNASEH2B-related type 1 interferonopathy 0 trials Sub-types →
- RNASEH2C-related type 1 interferonopathy 0 trials Sub-types →
- RNU7-1-related type 1 interferonopathy 0 trials Sub-types →
- SAMHD1-related type 1 interferonopathy 0 trials Sub-types →
- Sharpin-related autoinflammatory syndrome 0 trials
- Spondyloenchondrodysplasia with immune dysregulation 0 trials
- X-linked reticulate pigmentary disorder 0 trials
- Acroosteolysis dominant type 0 trials
- Aneurysmal bone cyst 0 trials
- Arterial tortuosity-bone fragility syndrome 0 trials
- Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation 0 trials
- Autoinflammatory disease, X-linked 0 trials
- Autoinflammatory disease, multisystem, with immune dysregulation, X-linked 0 trials Sub-types →
- Autoinflammatory disease, systemic, with vasculitis 0 trials
- Autoinflammatory syndrome with immunodeficiency 0 trials
- Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis 0 trials
- Autoinflammatory syndrome, familial, Behcet-like 0 trials Sub-types →
- Bone fragility with contractures, arterial rupture, and deafness 0 trials
- Brittle cornea syndrome 0 trials Sub-types →
- Chondrocalcinosis 2 0 trials
- Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome 0 trials
- Diaphyseal medullary stenosis-bone malignancy syndrome 0 trials
- Encephalocraniocutaneous lipomatosis 0 trials
- Familial ossifying fibroma 0 trials
- Hyperparathyroidism 1 0 trials
- Hyperparathyroidism 3 0 trials
- Hyperparathyroidism 4 0 trials
- Idiopathic juvenile osteoporosis 0 trials
- Jugulotympanic paraganglioma 0 trials Sub-types →
- Juvenile hyaline fibromatosis 0 trials
- Linkeropathy 0 trials Sub-types →
- Multiple epiphyseal dysplasia due to collagen 9 anomaly 0 trials Sub-types →
- Multiple symmetric lipomatosis 0 trials Sub-types →
- Neonatal inflammatory skin and bowel disease 0 trials Sub-types →
- Progeroid and marfanoid aspect-lipodystrophy syndrome 0 trials
- Pseudo-TORCH syndrome 2 0 trials
- Psoriasis 14, pustular 0 trials
- Pyogenic arthritis-pyoderma gangrenosum-acne syndrome 0 trials
- Thrombocytopenia 6 0 trials
- Trichohepatoenteric syndrome 0 trials Sub-types →
-
Disease of the tendon 126 trials · 192 incl. sub-types
3 sub-types
- Tendinitis 24 trials · 77 incl. sub-types Sub-types →
- Tendon sheath disorder 0 trials · 30 incl. sub-types Sub-types →
- Tendinosis 17 trials
-
Benign connective and soft tissue neoplasm 0 trials · 101 incl. sub-types
5 sub-types
- Bone benign neoplasm 1 trial · 70 incl. sub-types Sub-types →
- Benign soft tissue neoplasm 0 trials · 16 incl. sub-types Sub-types →
- Benign lipomatous neoplasm 0 trials · 15 incl. sub-types Sub-types →
- Benign osteogenic neoplasm 0 trials Sub-types →
- Lipofibromatosis 0 trials
-
Fasciitis 7 trials · 97 incl. sub-types
6 sub-types
- Plantar fasciitis 85 trials
- Necrotizing fasciitis 7 trials
- Eosinophilic fasciitis 1 trial
- Ischemic fasciitis 0 trials
- Nodular fasciitis 0 trials Sub-types →
- Proliferative fasciitis 0 trials
-
Collagenopathy 3 trials · 42 incl. sub-types
3 sub-types
- Type 2 collagenopathy 0 trials · 39 incl. sub-types Sub-types →
- Disseminated eosinophilic collagen disease 0 trials
- Multiple epiphyseal dysplasia due to collagen 9 anomaly 0 trials Sub-types →
-
Interstitial cystitis 39 trials
-
Periostitis 0 trials · 17 incl. sub-types
2 sub-types
- Alveolar periostitis 17 trials
- Orbital periostitis 0 trials
-
Synovitis 15 trials
1 sub-type
- Gonococcal synovitis 0 trials
-
Overlapping connective tissue disease 2 trials · 15 incl. sub-types
2 sub-types
- Mixed connective tissue disease 15 trials
- MASS syndrome 0 trials
-
Panniculitis 3 trials · 6 incl. sub-types
6 sub-types
- Lipodermatosclerosis 1 trial
- Nodular non-suppurative panniculitis 1 trial
- Panniculitis and localized lipodystrophy 1 trial
- Cytophagic histiocytic panniculitis 0 trials
- Erythema nodosum 0 trials
- Lupus erythematosus panniculitis 0 trials
-
Enthesopathy 2 trials · 4 incl. sub-types
5 sub-types
- Enthesitis 2 trials
- Fibular collateral ligament bursitis 0 trials
- Olecranon bursitis 0 trials
- Pes anserinus tendinitis or bursitis 0 trials
- Tibial collateral ligament bursitis 0 trials
-
Ochronosis disorder 1 trial
1 sub-type
- Exogenous ochronosis 0 trials
-
Ainhum 0 trials
-
Interstitial keratitis 0 trials
1 sub-type
- Diffuse interstitial keratitis 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 1006 trials in this tab.
-
Can a Chemo-Transplant combo rescue patients whose leukemia resists standard treatment?
Cure CompletedThis trial tests a treatment strategy for adults with acute myeloid leukemia (AML) that did not respond to standard induction chemotherapy. Participants receive clofarabine and intermediate-dose Ara-C chemotherapy, followed by a reduced-intensity allogeneic stem cell transplant u…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
Gentler transplant prep aims to cure tough blood cancers
Cure CompletedResearchers test a reduced-intensity conditioning regimen before allogeneic stem cell transplant in adults with high-risk AML, MDS, or ALL who cannot tolerate standard intensive treatment. The regimen combines clofarabine, busulfan, and thymoglobulin. The trial measures relapse r…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
HPV vaccine shows promise for girls on Immune-Suppressing drugs
Vaccine CompletedThis study looked at whether the HPV vaccine works in girls aged 9 to 17 who are taking medicines that weaken their immune system, such as after an organ transplant or for diseases like lupus. The goal was to see if their bodies produce enough antibodies to protect against HPV. T…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Vaccine
Last updated Jun 27, 2026 12:36 UTC
-
Shingles vaccine study shows promise for rheumatoid arthritis patients
Vaccine CompletedThis study looked at how safe and effective two shingles vaccines (Zostavax and Shingrix) are in people with rheumatoid arthritis who are taking the drug abatacept. About 154 adults took part, and researchers measured their immune response and any side effects. The goal was to se…
Phase 2 • Sponsor: Kevin Winthrop • Aim: Vaccine
Last updated Jun 27, 2026 12:29 UTC
-
Can a JAK1 pill calm sarcoidosis inflammation?
Disease control CompletedResearchers at Yale University are testing whether abrocitinib, an oral JAK1 inhibitor already approved for atopic dermatitis, can reduce inflammation in people with moderate to severe cutaneous sarcoidosis. The trial enrolls adults with a confirmed skin biopsy and a CSAMI activi…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Sep 21, 2026 15:00 UTC
-
Can a targeted immune drug calm rare muscle inflammation?
Disease control CompletedThis trial tests whether efgartigimod, an injected drug that blocks certain immune antibodies, can improve muscle strength and function in adults with active idiopathic inflammatory myopathy — a group of rare autoimmune diseases that cause muscle inflammation and weakness. About …
Phase 2/3 • Sponsor: argenx • Aim: Disease control
Last updated Sep 21, 2026 15:00 UTC
-
Can a p53-Targeting drug boost chemotherapy in Hard-to-Treat blood cancers?
Disease control CompletedResearchers are testing a drug called APR-246 combined with azacitidine in people with myeloid blood cancers that carry a TP53 mutation, including myelodysplastic syndrome, acute myeloid leukemia, myeloproliferative neoplasms, and chronic myelomonocytic leukemia. The trial aims t…
Phase 1/2 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Sep 21, 2026 15:00 UTC
-
New combo therapy aims to stop bone cancer from coming back
Disease control CompletedThis study tests whether giving a precise, high-dose radiation treatment (SBRT) to bone tumors before surgery is safe and can prevent the cancer from returning. About 39 adults with cancer that has spread to their bones and who need surgery to stabilize a fracture risk will recei…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 21, 2026 15:00 UTC
-
Old drugs, new hope: imatinib combo tested for rare tumors
Disease control CompletedThis early-phase trial tested two cancer drugs—imatinib mesylate and cyclophosphamide—given daily by mouth to 26 people with rare, advanced tumors that had no standard treatment. The main goal was to find the safest dose of imatinib when combined with a fixed dose of cyclophospha…
Phase 1 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control CompletedThis early-phase study tests a new drug called ERAS-601, alone or with other cancer treatments, in adults with advanced solid tumors that have not responded to standard therapies. The main goals are to find safe doses and check for side effects. About 90 participants will take pa…
Phase 1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could cord cell secretions ease arthritis pain?
Disease control CompletedThis study tests whether a substance produced by umbilical cord cells can help control moderate rheumatoid arthritis. Participants receive weekly injections of either the cell substance or a placebo for six weeks, alongside their usual medication. The goal is to see if it improve…
Phase 2 • Sponsor: Universitas Sriwijaya • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New pill could tame rare Muscle-Skin disease
Disease control CompletedThis phase 3 trial tests an oral drug called brepocitinib in 241 adults with dermatomyositis, a rare disease causing muscle weakness and skin rash. Participants receive either the drug or a placebo for 52 weeks to see if it improves symptoms. The study is active but no longer rec…
Phase 3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a simple abutment preserve bone and gums after tooth extraction?
Disease control CompletedThis trial investigates whether using a socket sealing abutment, with or without bone graft material, helps preserve bone and soft tissue after immediate molar implant placement. Adults aged 18-45 with non-restorable molars will receive the implant right after extraction, and the…
Sponsor: Mansoura University • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can an Anti-Inflammation drug make AML chemotherapy work better?
Disease control CompletedResearchers are testing whether adding tocilizumab, a drug that blocks an inflammation signal called IL-6, to standard chemotherapy helps adults with high-risk acute myeloid leukemia. Participants receive idarubicin and cytarabine, the usual induction chemotherapy, plus a single …
Phase 1 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a dual immune antibody plus radiation shrink metastatic sarcoma?
Disease control CompletedResearchers are testing a combination of the experimental antibody MEDI5752 and stereotactic body radiotherapy in people with metastatic soft tissue sarcoma that has spread to the lungs. MEDI5752 targets two immune checkpoints, PD-1 and CTLA-4, and the radiation is aimed at one l…
Phase 1 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can an approved arthritis drug stop early joint damage?
Disease control CompletedResearchers are testing whether apremilast helps people with early psoriatic arthritis that affects only a few joints. Participants have had symptoms for five years or less and still have joint pain and swelling despite stable treatment with NSAIDs or one conventional DMARD. The …
Phase 4 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can radiation boost a personalized prostate cancer vaccine?
Disease control CompletedResearchers are testing whether giving radiation therapy before sipuleucel-T, a personalized immunotherapy vaccine, works better than the vaccine alone in men with hormone-resistant prostate cancer that has spread. The trial enrolls about 51 participants and randomly assigns them…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Dietary change may curb recurrent c. diff in cancer patients
Disease control CompletedThis study tested whether eating less fat and more fiber can reduce the chance of a repeat Clostridioides difficile infection in cancer patients. Eight participants with leukemia, lymphoma, or other cancers followed a specific diet. Researchers tracked diarrhea and measured C. di…
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a liposomal chemo combo improve outcomes before stem cell transplant?
Disease control CompletedResearchers are testing whether a liposomal chemotherapy drug called CPX-351 works better than standard chemotherapy before an allogeneic stem cell transplant in adults with higher-risk myelodysplastic syndromes (MDS) or oligoblastic acute myeloid leukemia (AML). The trial enroll…
Phase 2 • Sponsor: GWT-TUD GmbH • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug shows promise for Long-Term control of back pain condition
Disease control CompletedThis study is testing the long-term safety and effectiveness of bimekizumab, a drug that reduces inflammation, in 508 adults with active axial spondyloarthritis (including ankylosing spondylitis). Participants who completed earlier trials will receive the drug for an extended per…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Nanobody injection put to the test against psoriatic arthritis
Disease control CompletedResearchers are testing an experimental drug called sonelokimab in adults with active psoriatic arthritis, a condition that causes painful, swollen joints along with skin psoriasis. The trial compares sonelokimab injections with placebo injections, and also includes a third group…
Phase 2 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could a common diabetes pill boost arthritis remission?
Disease control CompletedThis study tests whether adding metformin, a diabetes drug, to standard methotrexate therapy helps more people with rheumatoid arthritis achieve disease control. About 128 adults with active RA who have not recently taken methotrexate will receive either methotrexate plus metform…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can 3D-printed plastic implants keep eyes level after jaw tumor removal?
Disease control CompletedThis trial tests whether patient-specific PEEK implants, custom-made plastic pieces, can rebuild the bone under the eye after surgery to remove part of the upper jaw due to tumors. The goal is to keep the eye in its natural position and avoid a sunken appearance or vision problem…
Phase 4 • Sponsor: Alexandria University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a shorter drug combo improve outcomes for older AML patients?
Disease control CompletedResearchers are testing whether a combination of venetoclax and a three-day course of decitabine works better than the standard pairing of venetoclax and azacitidine for older or unfit adults newly diagnosed with acute myeloid leukemia. The trial enrolls 154 participants and comp…
Phase 3 • Sponsor: The Second Affiliated Hospital of Kunming Medical University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a targeted drug help patients with polymyalgia rheumatica stop steroids faster?
Disease control CompletedThis trial tests whether adding tofacitinib to a standard steroid treatment can better control polymyalgia rheumatica, a condition causing pain and stiffness in the shoulders and hips. Adults aged 50 to 88 with active disease will receive either tofacitinib plus a tapering course…
Phase 3 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug combo shows promise for Tough-to-Treat leukemia in younger patients
Disease control CompletedThis study tests a chemotherapy drug called CPX-351 in people under 60 with secondary acute myeloid leukemia (AML), a type of leukemia that develops after other blood disorders or cancer treatments. The goal is to see how well the drug can make the cancer disappear or improve blo…
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug shows promise for Long-Term psoriatic arthritis control
Disease control CompletedThis study looked at the long-term safety and effectiveness of bimekizumab in adults with active psoriatic arthritis. Over 1,100 people who completed earlier studies received the drug and were monitored for side effects and disease symptoms. The goal was to see if bimekizumab rem…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new injection calm rheumatoid arthritis? an early trial puts ZB002 to the test
Disease control CompletedThis early-stage trial evaluates an experimental drug called ZB002, given as an injection under the skin. In the first part, healthy volunteers receive a single dose to check safety and how the drug moves through the body. In the second part, people with rheumatoid arthritis rece…
Phase 1 • Sponsor: Zenas BioPharma (USA), LLC • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Old drug, new hope: enasidenib may ease anemia in blood cancer patients
Disease control CompletedThis early-phase trial tested the drug enasidenib in 17 people with low-risk myelodysplastic syndrome or a related leukemia who had anemia and did not have a specific gene mutation. The goal was to see if the drug could safely improve red blood cell counts and reduce the need for…
Phase 1/2 • Sponsor: Tian Yi Zhang • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Head-to-Head: which drug works better for psoriatic arthritis?
Disease control CompletedThis study tests whether bimekizumab works better than risankizumab for adults with active psoriatic arthritis (PsA), a condition causing joint pain and skin lesions. About 684 participants will receive one of the two drugs for 16 weeks. The main goal is to see who gets at least …
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a gut bacteria booster ease rheumatoid arthritis?
Disease control CompletedThis pilot study tested whether a butyrate supplement, a type of short-chain fatty acid, could change the gut microbiome and immune responses in people with rheumatoid arthritis who didn't respond well to methotrexate. Twenty participants took the supplement for up to two months.…
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Designer immune cells take on rare sarcomas
Disease control CompletedThis phase 2 trial tests a personalized cell therapy called Lete-Cel in 7 people with advanced synovial sarcoma or myxoid/round cell liposarcoma that has not been treated before. Participants receive their own immune cells that have been engineered to recognize and attack their c…
Phase 2 • Sponsor: USWM, LLC (dba US WorldMeds) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a new topical cream tame cutaneous lupus?
Disease control CompletedThis early-stage trial tests the safety and tolerability of SOF-SKN, a cream applied to the skin, in healthy volunteers aged 18 to 64. The study has two parts: one applies a single dose, and the other applies daily doses for two weeks, with escalating strengths. Researchers monit…
Early phase 1 • Sponsor: Noxopharm Limited • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a Three-Drug combo outsmart returning leukemia?
Disease control CompletedThis trial tests whether adding venetoclax to a standard chemotherapy pair (cytarabine and mitoxantrone) can help adults with acute myeloid leukemia that has relapsed or not responded to initial treatment. In the first phase, researchers find the highest safe dose of cytarabine w…
Phase 1/2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
RINVOQ tested in Real-World study for back pain disease
Disease control CompletedThis study tested the drug RINVOQ in 69 adults with ankylosing spondylitis, a type of arthritis that mainly affects the spine. Participants took RINVOQ as prescribed by their doctor and were followed for up to a year. The goal was to see how safe and effective the drug is in real…
Sponsor: AbbVie • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could your own tooth help your jawbone heal faster?
Disease control CompletedThis trial tests whether placing a graft made from the patient's own tooth and blood components into an extraction socket improves bone healing compared with letting the socket heal on its own. Adults with non-restorable teeth will receive either the graft or no graft, and resear…
Sponsor: Cairo University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New pill aims to keep chemo on track for GI cancer patients
Disease control CompletedThis study tests whether avatrombopag, a pill that boosts platelet production, can help people with gastrointestinal cancer who develop low platelets from chemotherapy. About 60 participants will receive either avatrombopag or a placebo. The goal is to see if the drug can raise p…
Phase 2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug aims to calm dangerous immune storms in Still's and lupus patients
Disease control CompletedThis study tested a drug called emapalumab in 33 children and adults with macrophage activation syndrome (MAS), a life-threatening immune overreaction, linked to Still's disease or lupus. The goal was to see if the drug could safely control the condition and reduce the need for h…
Phase 3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Two-Drug combo stop early rheumatoid arthritis in its tracks?
Disease control CompletedThis trial is testing whether combining certolizumab pegol, an injectable biologic, with methotrexate, a standard oral medication, can help adults with early active rheumatoid arthritis achieve and maintain remission. Participants are newly diagnosed, have not yet taken disease-m…
Phase 3 • Sponsor: UCB Pharma SA • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a Two-Drug combo quiet early rheumatoid arthritis for good?
Disease control CompletedThis trial tests whether combining certolizumab pegol (Cimzia) with methotrexate can help adults with early, active rheumatoid arthritis achieve and maintain low disease activity without flare-ups. Participants who already responded well to this combination in a prior study conti…
Phase 3 • Sponsor: UCB Pharma • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New hope for young bone cancer patients: drug combo targets tough tumors
Disease control CompletedThis study tests the drug regorafenib in 30 patients aged 9 to 21 with bone cancers (osteosarcoma or Ewing sarcoma) that have not responded to standard therapy. The goal is to see if the drug can help control the disease and improve survival, while also checking its safety. The a…
Phase 1/2 • Sponsor: Institute of Mother and Child, Warsaw, Poland • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New hope for psoriatic arthritis patients who failed Anti-TNF drugs
Disease control CompletedThis phase 3 study tests guselkumab (Tremfya) in 453 adults with active psoriatic arthritis who did not respond to or could not tolerate a prior anti-TNF drug. Participants receive either guselkumab or a placebo injection. The main goal is to see if guselkumab reduces joint swell…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a pill stop desmoid tumors from growing?
Disease control CompletedThis phase 3 trial investigates whether nirogacestat, an oral drug, can slow the growth of desmoid tumors (also called aggressive fibromatosis) in adults whose tumors are progressing. Half the participants receive nirogacestat, while the other half receive a placebo, in a double-…
Phase 3 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a new drug erase the last traces of leukemia?
Disease control CompletedThis phase 2 trial is testing whether adding venetoclax, a pill taken daily for 12 months, can reduce the number of leukemia stem cells that remain in the bone marrow of people with chronic myeloid leukemia (CML) who are already in deep molecular remission on standard TKI therapy…
Phase 2 • Sponsor: Thomas Ernst, PD Dr. med. • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a pill keep blood cancer at bay after a stem cell transplant?
Disease control CompletedThis phase III trial is testing whether taking oral azacitidine as a maintenance therapy after an allogeneic stem cell transplant can help prevent relapse in people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). Participants are randomly assigned to receive…
Phase 3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Leukemia drug holiday: study tests if patients can pause nilotinib
Disease control CompletedThis study looked at whether people with chronic myeloid leukemia (CML) who have done very well on the drug nilotinib can safely stop taking it. 215 patients who had been on nilotinib for at least two years and had very low levels of cancer cells were enrolled. The main goal was …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Leukemia drug holiday: can patients stop nilotinib and stay Cancer-Free?
Disease control CompletedThis study looked at whether people with chronic myeloid leukemia (CML) who had very low levels of cancer cells could safely stop taking the drug nilotinib (Tasigna). Participants had already been treated with imatinib (Gleevec) and then nilotinib for at least 3 years. The main g…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can engineered immune cells outsmart transplant-related cancer?
Disease control CompletedThis early-phase trial tests a new type of immunotherapy for people who develop a rare blood cancer called post-transplant lymphoproliferative disease (PTLD) after a solid organ transplant. The treatment uses the patient's own immune cells (T-cells) that are engineered to resist …
Early phase 1 • Sponsor: University College, London • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could less be more? testing whether kids can ease off arthritis meds
Disease control CompletedThis trial looks at whether children with juvenile spondyloarthritis who have stable, inactive disease can safely reduce or stop their TNFi medication without causing a flare. Participants are randomly assigned to continue their usual TNFi dose, take it less frequently, or stop i…
Phase 4 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Leukemia drug holiday: study finds many can stop imatinib without relapse
Disease control CompletedThis study looked at 220 adults with chronic myeloid leukemia who had been in deep remission for at least two years while taking imatinib. Researchers wanted to see if stopping the drug would cause the cancer to come back. They found that many patients stayed in remission after s…
Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a once-daily pill tame psoriatic arthritis in everyday life?
Disease control CompletedThis study tracks about 450 adults with active psoriatic arthritis who are prescribed upadacitinib (RINVOQ) by their doctor. Researchers will follow participants for up to 24 months to see how well the drug controls joint and skin symptoms when used alone or with methotrexate in …
Sponsor: AbbVie • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can filgotinib safely control rheumatoid arthritis over years? a large trial seeks answers.
Disease control CompletedThis trial is testing the long-term safety and tolerability of the drug filgotinib in people with rheumatoid arthritis who have already completed an earlier filgotinib study. Researchers are monitoring side effects, lab abnormalities, and vital signs over an extended period. The …
Phase 3 • Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New drug combo shows promise for Tough-to-Treat psoriatic arthritis
Disease control CompletedThis study tested whether combining two drugs (guselkumab and golimumab) works better than one drug alone for people with active psoriatic arthritis who didn't get enough relief from previous TNF-alpha blockers. 91 adults took part. The goal was to see if the combo could help mor…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Blood-Derived injection may heal stubborn knee tendon pain — trial puts it to the test
Disease control CompletedThis trial investigates whether a single injection of platelet-rich plasma (PRP), made from a person's own blood, can reduce pain and improve function in chronic patellar tendinopathy (knee tendon pain). The study includes 29 adults aged 18–65 who have had tendon pain for over th…
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug bimekizumab shows promise for psoriatic arthritis in phase 3 trial
Disease control CompletedThis Phase 3 trial tested bimekizumab, a drug given by injection, against a placebo in 400 adults with active psoriatic arthritis who had not responded well to TNF-alpha inhibitors. The study aimed to see if bimekizumab could reduce joint pain and swelling and improve daily funct…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug shows promise for controlling psoriatic arthritis symptoms
Disease control CompletedThis study tested a drug called bimekizumab in 852 adults with active psoriatic arthritis, a condition causing joint pain, swelling, and skin patches. Participants received either bimekizumab, a placebo, or an existing treatment (adalimumab). The main goal was to see if bimekizum…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New biologic drug aims to ease joint pain and swelling in Tough-to-Treat psoriatic arthritis
Disease control CompletedThis phase 3 trial tests whether risankizumab, an injectable biologic, can reduce joint pain and swelling in adults with moderately to severely active psoriatic arthritis who have not responded to or cannot tolerate other biologic treatments. Participants receive either risankizu…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Leukemia drug cocktail aims to boost remission in High-Risk patients
Disease control CompletedThis study tests whether adding the targeted drug venetoclax to standard chemotherapy helps more adults with acute myeloid leukemia (AML) achieve remission. It enrolls people aged 18 to 65 with intermediate- or high-risk AML who have not yet been treated. The main goal is to see …
Phase 2 • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a peer coach help young people take control of their chronic illness?
Disease control CompletedThis study tests whether a peer coaching program delivered by phone and text can help adolescents and young adults (ages 16–22) with chronic conditions like sickle cell disease, diabetes, or cystic fibrosis improve their self-management skills. Participants are paired with a trai…
Sponsor: Duke University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Shock waves could soften hand contractures without surgery
Disease control CompletedThis study tests whether extracorporeal shock wave therapy can reduce the thickness of fibrous tissue in the hand caused by palmar fibromatosis (Dupuytren's contracture). Adults aged 18 to 70 with nodules, cords, or contractures will receive either shock wave therapy plus standar…
Sponsor: Cairo University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Real-World check: does bosutinib control CML safely?
Disease control CompletedThis study tracks the safety and effectiveness of bosutinib (Bosulif) in people with chronic myelogenous leukemia (CML) who are either newly diagnosed or have not responded to or tolerated prior treatments. Researchers will monitor side effects and how well the drug controls the …
Sponsor: Pfizer • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Rheumatoid arthritis drug safety showdown: baricitinib vs. TNF inhibitors
Disease control CompletedThis study compares the safety of baricitinib, an oral medication, against TNF inhibitors (injectable drugs like etanercept and adalimumab) in people with rheumatoid arthritis. The main focus is on the risk of venous thromboembolism (blood clots in veins). Participants include th…
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Blood cancer drug shows promise in Long-Term study
Disease control CompletedThis study follows 36 Italian patients with Polycythemia Vera who responded well to Ropeginterferon alfa-2b in an earlier trial. Researchers will check every 6 months whether the treatment continues to keep their red blood cell levels normal and prevent the disease from getting w…
Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Simple stretching program may counteract Diabetes-Related muscle stiffness
Disease control CompletedThis study investigates whether a passive stretching program can reduce muscle and tendon stiffness in people with type 2 diabetes. Diabetes can cause muscles and tendons to become stiffer, making walking harder and increasing energy use. The trial compares stiffness in people wi…
Sponsor: Universita di Verona • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Drug cocktail aims to tame advanced leukemia
Disease control CompletedThis phase 2 trial is testing whether combining two drugs, ponatinib and 5-azacitidine, can improve survival in people with advanced chronic myeloid leukemia (CML). The study includes adults whose CML has progressed to an accelerated phase or a more aggressive blast crisis. Parti…
Phase 2 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Personalized dasatinib dosing aims to tame leukemia with fewer side effects
Disease control CompletedThis study tests whether adjusting the daily dose of the leukemia drug dasatinib based on a patient's blood levels can improve safety and effectiveness. Adults newly diagnosed with chronic phase chronic myeloid leukemia (CML) will receive either standard dosing or a dose tailored…
Phase 2 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Diabetes drug could help eradicate hidden leukemia cells
Disease control CompletedThis phase 2 trial tests whether adding pioglitazone (a diabetes drug) to the standard leukemia medication imatinib can eliminate remaining cancer cells in people with chronic-phase chronic myeloid leukemia (CML). Participants must have been on imatinib for at least two years and…
Phase 2 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug combo aims to outsmart aggressive leukemia
Disease control CompletedThis trial tests whether adding the targeted drug ponatinib to standard chemotherapy (cytarabine) can help prevent relapse in adults with a specific, high-risk genetic form of acute myeloid leukemia (FLT3-ITD AML) who are already in first remission. The study includes two age gro…
Phase 1/2 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Personalizing leukemia drug doses could boost treatment success
Disease control CompletedThis trial investigates whether adjusting the dose of imatinib (Gleevec) based on the drug's level in the blood can improve outcomes for people newly diagnosed with chronic phase chronic myeloid leukemia (CML). Participants whose imatinib blood level is low after 28 days are rand…
Phase 2 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Your plate may fight psoriatic arthritis: diet study tests food as medicine
Disease control CompletedThis study investigates whether changing diet can reduce disease activity in people with psoriatic arthritis. Participants are randomly assigned to one of two diets: one focusing on which foods are eaten, and another limiting daily calorie intake. The trial lasts 24 weeks and inc…
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a pill keep AML at bay? new study tests maintenance therapy after chemo
Disease control CompletedThis study looked at whether taking oral azacitidine (Onureg) as maintenance therapy can help older adults with acute myeloid leukemia (AML) stay in remission longer after treatment with CPX-351 chemotherapy. The study included 100 patients aged 65 and older who had achieved remi…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug cocktail shows promise for Tough-to-Treat leukemia in seniors
Disease control CompletedThis study tested a chemotherapy drug called CPX-351 in 59 adults aged 60 to 75 with a high-risk form of acute myeloid leukemia (AML). The goal was to see how well it could put the cancer into remission. Participants received the drug through an IV, and some also had a stem cell …
Phase 2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Rheumatoid arthritis drug baricitinib put to the test against TNF blockers in major safety trial
Disease control CompletedThis completed Phase 4 study compared the safety of baricitinib (a daily pill) to TNF inhibitors (injections) in over 2,600 adults with rheumatoid arthritis. The main goal was to see if baricitinib had a higher risk of blood clots. Participants had to be at least 60, have a histo…
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Short exercise program may cut heart risk in arthritis patients
Disease control CompletedThis completed study tested whether a 6-week cardiac rehabilitation program (aerobic and resistance exercises) could improve heart disease risk, blood pressure, and arthritis activity in 40 people with both rheumatoid arthritis and high blood pressure. Participants were randomly …
Sponsor: Kayseri City Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo aims to shrink fibroids in pregnant women
Disease control CompletedThis study tested a drug called SB-UF, which combines hormones and a plant extract, to see if it can shrink uterine fibroids in pregnant women. 66 women took the drug or a placebo throughout their pregnancy. The goal was to reduce fibroid size and help them disappear, which could…
Phase 4 • Sponsor: Trieu, Nguyen Thi, M.D. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug could help patients with painful muscle disease ditch steroids
Disease control CompletedThis phase 3 trial tested whether abatacept, a drug that calms the immune system, can control polymyalgia rheumatica (a painful inflammatory condition) without the need for long-term steroids. Thirty-four adults with early disease received either abatacept or a placebo for 12 wee…
Phase 3 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for leukemia patients: asciminib shows promise in indian study
Disease control CompletedThis study looked at the safety and effectiveness of a drug called asciminib in 85 Indian adults with a specific type of leukemia (Ph+ CML-CP). Some participants had a genetic mutation (T315I) that can make treatment harder, while others had already tried two or more other drugs.…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New lupus drug shows promise in early safety trial
Disease control CompletedThis early-stage trial tested a drug called itolizumab (EQ001) in 52 adults with lupus, some of whom also had active kidney inflammation. The main goal was to check safety and find the right dose. Researchers also looked at how the drug behaves in the body and how it affects immu…
Phase 1 • Sponsor: Biocon Limited • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Real-World lupus study reveals how new drug performs outside clinical trials
Disease control CompletedThis study looked at 152 adults with systemic lupus erythematosus (SLE) who started taking anifrolumab during its first year on the market in Spain. Researchers tracked their disease activity, flare-ups, and remission rates using standard medical records. The goal was to see how …
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Can a blood flow drug ease painful finger ulcers in scleroderma?
Disease control CompletedThis study tested the drug bosentan in 18 adults with systemic sclerosis who had reduced blood flow in their hands and a history of digital ulcers. The goal was to see if bosentan could improve hand blood flow measured by laser imaging and how blood flow relates to ulcer severity…
Phase 4 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
One cord blood unit may replace two in stem cell transplants for blood cancer
Disease control CompletedThis study tested a new way to treat blood cancers like leukemia in 16 adults who did not have a standard bone marrow donor. Doctors used a single unit of cord blood that was grown in a lab to increase the number of stem cells before transplant. The goal was to see if this method…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo shows promise for High-Risk leukemia patients
Disease control CompletedThis study tested a new treatment for adults with a high-risk form of acute promyelocytic leukemia (APL). The experimental therapy combined arsenic trioxide, ATRA, and a low dose of idarubicin, aiming to improve survival and reduce side effects compared to the standard chemothera…
Phase 3 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New chemo cocktail aims to beat back leukemia relapse
Disease control CompletedThis phase 2 trial tests whether a combination of clofarabine and intermediate-dose cytarabine (CLARA) works better than high-dose cytarabine (HDAC) alone as consolidation therapy for younger adults (18-60) with newly diagnosed acute myeloid leukemia (AML). After initial remissio…
Phase 2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Text reminders and calls help veterans take lifesaving pills
Disease control CompletedThis study tested a program to help veterans with heart disease or rheumatic conditions take their medications as prescribed. Over 5,000 participants received reminders via text or phone calls, with extra support if needed. The goal was to improve medication adherence and reduce …
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a second-line drug help CML patients stay cancer-free without daily pills?
Disease control CompletedThis study looked at 31 adults with chronic myeloid leukemia (CML) whose cancer came back after they stopped taking imatinib. They were given nilotinib, a more powerful targeted therapy, to see if it could make their cancer undetectable again and allow them to stop treatment once…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a diabetes drug tame obesity caused by brain tumor treatment?
Disease control CompletedThis study tested whether exenatide, a diabetes drug, plus lifestyle changes helps adults with severe weight gain after treatment for a rare brain tumor (craniopharyngioma). 42 adults aged 18-75 took either exenatide or a placebo for 6 months. The main goal was to see if they los…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Real-world filgotinib study tracks arthritis control over 2 years
Disease control CompletedThis study followed 155 French adults with moderate-to-severe rheumatoid arthritis who were prescribed filgotinib (Jyseleca) for the first time. Over two years, researchers measured how many patients stayed on the drug and how well it controlled their disease activity. The goal w…
Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for stroke survivors with rare clotting disorder: rivaroxaban vs warfarin
Disease control CompletedThis study tested whether the drug rivaroxaban works as well as warfarin to prevent further brain damage in people who have had a stroke due to antiphospholipid syndrome (APS), a condition that causes abnormal blood clotting. About 40 participants took either rivaroxaban or warfa…
Phase 2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Daily painkillers may shield spines in arthritis patients on biologics
Disease control CompletedThis study looked at whether taking NSAIDs every day, instead of only when needed, can prevent spine damage in people with ankylosing spondylitis who are also receiving anti-TNF therapy. 188 adults participated in this Phase 3 trial. The goal was to see if continuous NSAID use re…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New lupus pill shows promise in Mid-Stage trial
Disease control CompletedThis study tested an oral medication called GLPG3667 in 186 adults with active systemic lupus erythematosus (SLE). Participants took the drug or a placebo once daily for 48 weeks. The goal was to see if the drug could reduce lupus disease activity and improve symptoms, while moni…
Phase 2 • Sponsor: Lakefront Biotherapeutics NV • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New birth control pill aims to help women with painful conditions
Disease control CompletedThis study tested whether a daily combination pill (relugolix, estradiol, and norethindrone acetate) can prevent pregnancy in women aged 18 to 50 who have uterine fibroids or endometriosis. Over 1,100 women took the pill for up to a year, and researchers counted how many became p…
Phase 3 • Sponsor: Sumitomo Pharma Switzerland GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Cancer drug shows promise for rare skin disease
Disease control CompletedThis study tested whether imatinib, a drug used for certain cancers, can reduce skin hardening in people with severe scleroderma. 28 adults received either imatinib or a placebo for 6 months. The main goal was to see if the drug improved skin thickness and quality of life.
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New pill could ease rare muscle disease
Disease control CompletedThis study tested an oral drug called GLPG3667 (Cadefrecitinib) in 40 adults with dermatomyositis, a rare disease causing muscle weakness and skin rash. Participants took the drug or a placebo daily for 24 weeks to see if it improves symptoms. The trial is complete, and results w…
Phase 2 • Sponsor: Lakefront Biotherapeutics NV • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a viagra drug heal scleroderma finger sores?
Disease control CompletedThis study tested whether sildenafil (the drug in Viagra) can help heal painful finger ulcers in people with scleroderma, a disease that damages blood vessels. 84 participants took either sildenafil or a placebo three times daily for 90 days. The main goal was to see if the ulcer…
Phase 3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Pill may replace shots for blood cancer patients, study finds
Disease control CompletedThis study tested whether an oral medication (CC-486) could help elderly patients with a serious blood disorder called myelodysplastic syndrome (MDS) maintain their improvement after initial injectable treatment. Eleven patients who had responded to injectable azacitidine switche…
Phase 2 • Sponsor: University of Florence • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Stem cells and oxygen therapy may save hips from collapse
Disease control CompletedThis study tested a triple therapy—surgery, stem cells, and hyperbaric oxygen—in 24 patients with early-stage osteonecrosis (bone death) of the hip. After two years, patients reported better hip function and fewer needed a hip replacement. The approach aims to stop the bone from …
Sponsor: Ankara City Hospital Bilkent • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a blood vessel drug save kidneys in scleroderma crisis?
Disease control CompletedThis study tested a drug called bosentan in 16 adults with scleroderma who had a serious kidney complication called scleroderma renal crisis. The goal was to see if bosentan could help protect kidney function and improve survival over 6 months to a year. The drug works by blockin…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New knee prosthesis helps bone cancer patients walk again
Disease control CompletedThis study looked at how well a special knee replacement (MUTARS) works after removing bone cancer. Nine patients were checked to see if they could lock their new knee and walk actively. The goal was to understand if the prosthesis helps with daily movement and walking.
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo shows promise for rare childhood muscle disease
Disease control CompletedThis study tested the drug baricitinib, given with steroids, in 16 children aged 3-18 with newly diagnosed juvenile dermatomyositis, a rare disease causing muscle weakness and skin rashes. The goal was to see if baricitinib works better than the standard treatment (methotrexate p…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a lupus drug shield organs from Long-Term harm?
Disease control CompletedThis study looked at whether the drug anifrolumab, when added to standard lupus treatments, can reduce long-term organ damage compared to standard care alone. Researchers analyzed data from 561 adults with active lupus, comparing those who took anifrolumab in earlier trials to si…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kids with lupus: drug trial shows promise
Disease control CompletedThis study tested the drug belimumab in children aged 5 to 17 with active lupus. Participants received either belimumab or a placebo alongside their usual treatments. The goal was to see if belimumab could safely reduce lupus disease activity over 52 weeks.
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New psoriasis drug shows promise in major trial
Disease control CompletedThis study tested a new drug called bimekizumab in 567 adults with moderate to severe plaque psoriasis. Participants received either bimekizumab, a placebo, or another active drug. The main goal was to see how well bimekizumab cleared skin lesions after 16 weeks. Results showed s…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug bimekizumab shows promise in clearing psoriasis in phase 3 trial
Disease control CompletedThis phase 3 study tested bimekizumab, a drug given by injection, against a placebo in 435 adults with moderate to severe plaque psoriasis. The main goal was to see how many people achieved at least 90% skin clearing after 16 weeks. The trial also looked at complete clearing and …
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Ultrasound may spot arthritis Flare-Ups before symptoms start
Disease control CompletedThis study tested whether ultrasound could detect signs of rheumatoid arthritis (RA) relapse before symptoms appear in patients treated with rituximab. Thirty adults with RA who had not responded to at least one TNF-blocking drug were included. Researchers used ultrasound to meas…
Phase 4 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Arthritis patients may swap IV infusions for convenient at-home shots
Disease control CompletedThis study tested whether people with rheumatoid arthritis, psoriatic arthritis, or spine arthritis could safely switch from receiving infliximab through an IV infusion at a clinic to giving themselves a simple shot under the skin at home. 22 adults who were already stable on IV …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug combo aims to prevent leukemia return after remission
Disease control CompletedThis study tested whether a combination of two drugs, venetoclax and azacitidine, can help adults with acute myeloid leukemia (AML) stay in remission after initial chemotherapy. The goal was to find the right dose and see if it safely delays the cancer from coming back. The study…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a probiotic help kids with arthritis?
Disease control CompletedThis study tested whether taking a probiotic called VSL#3, alongside standard treatment, can reduce disease activity in children with juvenile idiopathic arthritis (JIA). Fifty-one children aged 1 to 7 with specific types of JIA took either the probiotic or a placebo. Researchers…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a second drug stop the body from rejecting arthritis treatment?
Disease control CompletedThis study looked at whether adding methotrexate to adalimumab (a biologic drug) reduces the chance that the body makes antibodies against adalimumab in people with ankylosing spondylitis. About 110 adults with active disease who did not respond well to NSAIDs took part. The goal…
Phase 4 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New radiation approach aims to tame pituitary tumors with fewer side effects
Disease control CompletedThis study tested a new way of delivering radiation for people with non-secreting pituitary adenomas that came back or remained after surgery. Instead of a single high dose, the radiation was given in five smaller daily doses. The goal was to see if this approach could control tu…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Stem cell transplant shows promise for scleroderma patients
Disease control CompletedThis study compared two treatment strategies for people with early, severe scleroderma: a stem cell transplant using their own cells versus standard immunosuppressive drugs. The trial enrolled 60 adults with diffuse cutaneous systemic sclerosis. The goal was to see which approach…
Phase 4 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New study: can upadacitinib ease back pain in axial spondylarthritis?
Disease control CompletedThis study looked at how well upadacitinib, an anti-inflammatory pill, controls pain in people with axial spondylarthritis (axSpA), a condition causing chronic back pain. Over 700 adults from 19 countries took the drug as prescribed by their doctors and were followed for 12 month…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Kids with quiet arthritis may taper meds without Flare-Ups, study finds
Disease control CompletedThis study looked at 62 children with juvenile idiopathic arthritis whose disease was inactive. Researchers tested whether slowly reducing and then stopping their biologic medication was as safe and effective as staying on the full dose for 24 weeks. The goal was to see if taperi…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo therapy aims to shrink spleens in bone marrow cancer patients
Disease control CompletedThis study tested whether adding the experimental drug navitoclax to the standard drug ruxolitinib works better than ruxolitinib alone for people with myelofibrosis, a type of bone marrow cancer. The main goal was to see if the combination could shrink an enlarged spleen by at le…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can kids with cancer stop antibiotics sooner? new trial investigates
Disease control CompletedThis study looked at whether children with cancer and a fever caused by low white blood cells can safely stop antibiotics earlier than usual. 55 children took part, and half stopped antibiotics once their fever was gone for 48 hours, while the other half continued until their whi…
Phase 4 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New scleroderma pill shows promise in slowing lung damage
Disease control CompletedThis study tested a medicine called Avenciguat (BI 685509) in 214 adults with scleroderma, a disease that can cause skin hardening and lung or blood vessel damage. Participants took either the study drug or a placebo three times daily for at least 11 months. Researchers measured …
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New dosing study aims to tame Drug-Resistant leukemia
Disease control CompletedThis study tested three different starting doses (45 mg, 30 mg, and 15 mg daily) of the drug ponatinib in 283 adults with chronic phase chronic myeloid leukemia (CML) that had stopped responding to other treatments or had a specific genetic mutation (T315I). The main goal was to …
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Last-resort leukemia combo shows early promise in tiny trial
Disease control CompletedThis early-phase study tested a combination of two drugs, venetoclax and omacetaxine, in 6 adults with acute myeloid leukemia (AML) whose cancer had stopped responding to venetoclax-based treatments. The main goal was to find the safest dose of omacetaxine when given with venetoc…
Phase 1 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Microtransplant without immune drugs shows promise for leukemia patients too sick for standard transplant
Disease control CompletedThis early-phase trial tested a new type of stem cell transplant called a microtransplant in 25 people with myeloid blood cancers (like leukemia) who were too old or frail for a standard transplant. Unlike a regular transplant, this one used stem cells from a partially matched fa…
Phase 1 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
One donor, two transplants: could this end lifelong Anti-Rejection drugs?
Disease control CompletedThis pilot study tested a combined bone marrow and kidney transplant from a partially matched family donor in 10 people with both a blood disorder and chronic kidney disease. The goal was to treat both conditions at once and possibly reduce the need for lifelong anti-rejection dr…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug aims to tame blood vessel inflammation without steroids
Disease control CompletedThis study tested the drug secukinumab (Cosentyx) in 151 adults with newly diagnosed giant cell arteritis, a condition causing inflamed blood vessels. Participants were in remission and received either secukinumab or a placebo, along with a steroid taper. The goal was to see if s…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New pill shows promise for treating spinal arthritis in large trial
Disease control CompletedThis study tested a daily pill called upadacitinib in 734 adults with axial spondyloarthritis, a type of arthritis that causes pain and stiffness in the spine. The drug was compared to a placebo to see if it could reduce symptoms and control the disease. Results showed that upada…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New combo therapy shows promise for kids with stubborn arthritis
Disease control CompletedThis study tested whether adding leflunomide to standard methotrexate treatment helps children with polyarticular juvenile idiopathic arthritis (JIA) that did not improve with methotrexate alone. Fifty children were randomly assigned to receive either the combination or methotrex…
Phase 4 • Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Radioactive drug shows promise for Tough-to-Treat prostate cancer
Disease control CompletedThis study tested a radioactive drug called radium-223 in 921 men with advanced prostate cancer that no longer responds to hormone therapy and has spread to the bones. The goal was to see if it helps them live longer and controls the cancer. Participants received either the drug …
Phase 3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New combo therapy shows promise for rare liposarcoma
Disease control CompletedThis phase 2 study tested whether adding pioglitazone (a diabetes drug) to trabectedin (a chemotherapy) could help shrink or control liposarcoma, a rare cancer of fat tissue. The study included 10 patients whose tumors had stopped growing but not shrunk with trabectedin alone. Re…
Phase 2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Experimental combo shows promise for rare sarcomas
Disease control CompletedThis early-phase study tested whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (gemcitabine) is safe for people with two rare types of soft tissue sarcoma (leiomyosarcoma and undifferentiated pleomorphic sarcoma). Twenty-five adults with advanced or in…
Phase 1/2 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo therapy aims to improve life quality in AML patients too sick for standard chemo
Disease control CompletedThis study looked at how adults with a specific type of acute myeloid leukemia (AML) who cannot receive standard chemotherapy feel and function while taking a combination of ivosidenib and azacitidine. The main goal was to measure quality of life using questionnaires, along with …
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for sarcoidosis patients: inhaled drug targets lung and heart strain
Disease control CompletedThis study tested an inhaled medication called treprostinil in 5 people with sarcoidosis who also have lung scarring and high blood pressure in the lungs. The goal was to see if the drug could improve blood flow and heart function. Participants took the drug and were monitored wi…
Phase 2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for PMR patients: drug may reduce need for steroids
Disease control CompletedThis study tested whether rituximab, a drug that calms the immune system, can help people with polymyalgia rheumatica (PMR) stop taking steroids sooner. PMR causes pain and stiffness, and steroids are the main treatment but have side effects. The trial included 114 newly diagnose…
Phase 3 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Head-to-Head: which drug works better for psoriatic arthritis in the real world?
Disease control CompletedThis study looked at 70 people with psoriatic arthritis to compare two drug types: upadacitinib and IL-17 inhibitors. Researchers tracked joint and skin symptoms over 24 weeks in routine care. The goal is to see which works better in real life, helping doctors personalize treatme…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Promising chemo cocktail shows hope for AML patients under 60
Disease control CompletedThis study tested a three-drug chemotherapy combination (cladribine, homoharringtonine, and cytarabine) in 65 adults under 60 with newly diagnosed acute myeloid leukemia (AML). The goal was to see how well it wiped out leukemia cells and how safe it was. Results tracked complete …
Phase 2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Weekly shot may halt arthritis progression in kids
Disease control CompletedThis study tested whether a weekly injection of abatacept (Orencia) plus usual care could prevent juvenile idiopathic arthritis (JIA) from spreading to more joints or causing eye inflammation. 121 children with recent-onset JIA affecting 4 or fewer joints took part. The goal was …
Phase 3 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Freezing out tumors: new hope for rare desmoid disease
Disease control CompletedThis study tested a freezing technique called cryoablation on 50 adults with desmoid tumors that had grown despite medical treatment. The goal was to stop tumor growth and ease symptoms without surgery. Researchers used MRI to guide the freezing and check results one year later.
Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Which biologic works best after Anti-TNF failure? study seeks answers
Disease control CompletedThis study looked at 300 adults with active rheumatoid arthritis whose first anti-TNF treatment stopped working. Researchers compared two strategies: switching to a different type of biologic drug or trying a second anti-TNF. The goal was to see which approach better controls the…
Phase 4 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for myelofibrosis patients: drug combo shows promise in shrinking spleens
Disease control CompletedThis study tested a drug called navitoclax, either alone or added to the standard drug ruxolitinib, in 191 people with myelofibrosis. The main goal was to see if the treatment could shrink the spleen by at least 35% after 24 weeks. The trial also looked at whether it could reduce…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New bone graft shows promise for repairing Cancer-Damaged spines
Disease control CompletedThis study tested a new bone graft material, ZetaMet, in 10 women with breast cancer that spread to their spine, causing bone defects. The graft was implanted into the damaged vertebra to see if it could safely stabilize the spine and reduce pain. The main goals were to track com…
Phase 2 • Sponsor: Zetagen Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Biosimilar switch works for most patients in Real-World study
Disease control CompletedThis study tested what happens when patients with rheumatoid arthritis, Crohn's disease, or eye inflammation switch from the original drug Remicade to its lower-cost biosimilar Inflectra. Over 260 adults who had been on Remicade for at least 4 months were switched. The main goal …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New injection aims to retrain immune cells to fight arthritis
Disease control CompletedThis early study tested a new drug called EF-M2 (Immutalon) in 48 adults with moderate-to-severe rheumatoid arthritis. The drug is designed to shift immune cells from a pro-inflammatory to an anti-inflammatory state. Participants received injections for 4 weeks, and researchers m…
Phase 1/2 • Sponsor: S.LAB (SOLOWAYS) • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New daily pill shows promise for rheumatoid arthritis in early trial
Disease control CompletedThis Phase 2 trial tested Proximod, a daily pill that calms the immune system, in 179 adults with moderate-to-severe rheumatoid arthritis who had not responded well to standard treatments. Participants took either 5 mg, 10 mg, or a placebo daily for three months, with one month o…
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can a daily antibiotic stop deadly infections in blood cancer patients?
Disease control CompletedThis study tested whether the antibiotic levofloxacin can prevent fevers and infections in people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) who are receiving the chemotherapy drug azacitidine. Infections are a major risk for these patients. The trial ran…
Phase 3 • Sponsor: Centre Henri Becquerel • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New combo therapy aims to improve lung function in stubborn lung disease
Disease control CompletedThis study tested whether adding rituximab (a drug that calms certain immune cells) to standard mycophenolate mofetil treatment helps people with interstitial lung disease whose lungs are not responding to initial therapy. 122 adults with various ILD types received either rituxim…
Phase 3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Brushing teeth during aplasia: safe or risky?
Disease control CompletedThis study tested whether brushing teeth is safe for patients with prolonged aplasia (low blood cell counts) after intensive chemotherapy. Currently, many hospitals only allow mouthwash to avoid bleeding and infection. The trial compared brushing with an extra-soft toothbrush plu…
Phase 3 • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New artery-delivered combo shows promise against bone cancer
Disease control CompletedThis early-phase trial tested a new approach for osteosarcoma (bone cancer) in 10 patients aged 12-40. The treatment combined standard chemotherapy with a targeted drug (Endostar) and cisplatin delivered directly into the artery supplying the tumor. The goal was to see if this me…
Phase 1/2 • Sponsor: Shanghai 6th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug shows promise for back pain from ankylosing spondylitis
Disease control CompletedThis study tested a drug called bimekizumab in 332 adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants received either the drug or a placebo injection. The goal was to see if the drug could reduce symptoms like pain and…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New shoulder implant shows promise for arthritis patients
Disease control CompletedThis study tested a new shoulder implant called PyroTITAN HRA in 156 people with arthritis. The implant resurfaces the ball part of the shoulder joint to relieve pain and improve function. Researchers tracked how long the device lasted and whether it caused problems, aiming to se…
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Gum treatment may ease arthritis symptoms, study finds
Disease control CompletedThis study looked at whether treating gum disease (periodontitis) can reduce the severity of rheumatoid arthritis (RA) in people who have both conditions. Researchers enrolled 22 adults with RA and gum disease, providing periodontal treatment and measuring changes in RA activity …
Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Real-World study checks how well venetoclax works for AML patients
Disease control CompletedThis study looked at how well the drug Venetoclax works for adults with acute myeloid leukemia (AML) who are not healthy enough for intensive chemotherapy. About 120 patients in Switzerland and Austria took Venetoclax pills daily as part of their normal care. Researchers tracked …
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New combo shows promise for rare cancers
Disease control CompletedThis study tested a combination of two drugs—pembrolizumab (an immunotherapy) and cyclophosphamide (a chemotherapy)—in 129 people with advanced sarcomas that had spread or could not be removed by surgery. The goal was to see if the combination could shrink tumors or stop them fro…
Phase 2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug cocktail shows promise for rare sarcomas
Disease control CompletedThis study tested a combination of two drugs, lenvatinib and eribulin, in 30 people with advanced soft tissue sarcomas (liposarcoma or leiomyosarcoma) that could not be removed by surgery or had spread. The goal was to see if the combo could shrink tumors or slow their growth. Th…
Phase 1/2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New combo therapy shows promise for early psoriatic arthritis patients
Disease control CompletedThis study tested whether adding GOLimumab to methotrexate works better than methotrexate alone for people with very early psoriatic arthritis (PsA). 84 adults with active PsA diagnosed within the last 2 years took part. The main goal was to see if the combination improved diseas…
Phase 3 • Sponsor: The Leeds Teaching Hospitals NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Massive study tests everyday supplements against autoimmune disease and aching knees
Disease control CompletedThis large study looked at whether taking daily vitamin D or fish oil supplements could lower the risk of developing autoimmune diseases (like rheumatoid arthritis), reduce signs of inflammation in the blood, and ease chronic knee pain. Over 25,000 adults without prior cancer or …
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Steroid-Free hope for arthritis patients?
Disease control CompletedThis study tested two methods to help people with rheumatoid arthritis stop taking steroids (prednisone) safely. 102 adults with low disease activity or remission were given either a gradual dose reduction or a replacement with hydrocortisone. The goal was to see which approach a…
Phase 4 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Knee implant showdown: which one works better?
Disease control CompletedThis study compared two types of knee implants—the Vanguard Cruciate Retaining and the AGC Total Condylar—in 150 patients with knee arthritis. The goal was to see which implant provides better pain relief and function after knee replacement surgery. Patients were followed for sev…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Study tests if starting stronger drugs earlier tames psoriatic arthritis
Disease control CompletedThis completed trial tested whether starting stronger medications early helps people with moderate to severe psoriatic arthritis more than the usual step-up approach. 192 adults were randomly assigned to standard care, early combination disease-modifying drugs, or early TNF inhib…
Phase 4 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a cancer drug ease arthritis in scleroderma patients?
Disease control CompletedThis study tested whether rituximab, a drug used for certain cancers and autoimmune diseases, can reduce joint pain and swelling in people with systemic sclerosis (scleroderma). Twenty-two adults with active arthritis took rituximab or a placebo, plus standard care. Researchers c…
Phase 2/3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can flu shots protect autoimmune patients?
Disease control CompletedThis study looked at how well flu vaccines (seasonal and H1N1) work in 234 adults with autoimmune diseases like lupus or vasculitis, some of whom were on steroids or immunosuppressants. Researchers measured antibody levels three weeks after each shot to see if the vaccine provide…
Phase 4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Fibroid treatment showdown: surgery or embolization for better baby chances?
Disease control CompletedThis study compared two treatments for symptomatic uterine fibroids—surgery (myomectomy) and a minimally invasive procedure (uterine artery embolization)—to see which one better helps women get pregnant and have a live birth. It included 9 women aged 18 to 43 with fibroids larger…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug shows promise for lupus and kidney complications
Disease control CompletedThis study tested a new drug called KZR-616 (zetomipzomib) in 69 people with lupus, some of whom also had kidney inflammation (lupus nephritis). Participants received weekly injections for 13 or 24 weeks. The main goals were to check safety and see if the drug could reduce protei…
Phase 1/2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Experimental drug KZR-616 tested for rare muscle disorders
Disease control CompletedThis Phase 2 trial tested a drug called KZR-616 (zetomipzomib) in 25 adults with active polymyositis or dermatomyositis, two rare diseases that cause muscle inflammation and weakness. Participants received either the drug or a placebo for 16 weeks, then switched to the other trea…
Phase 2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New IV drug shows promise for kids with stubborn arthritis
Disease control CompletedThis study tested an intravenous drug called golimumab in 130 children with active juvenile idiopathic arthritis that did not improve with methotrexate. The main goal was to measure how the drug moves through the body over time. The study was completed and provides information on…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
App helps young cancer survivors shed pounds
Disease control CompletedThis study tested a smartphone app to help young adult cancer survivors (ages 18-39) lose weight. The app tracked diet and activity as part of a behavioral weight loss program. The goal was to see if this approach was practical and well-liked by participants. The study involved 6…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New program aims to cut heart risk in rheumatoid arthritis patients
Disease control CompletedThis study tested a program to help people with rheumatoid arthritis (RA) get their cholesterol checked and treated. Many RA patients are at higher risk for heart attacks and strokes but often miss out on proper screening. The program used peer coaches and educational materials t…
Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for AML patients: Three-Drug cocktail shows promise in phase 2 trial
Disease control CompletedThis study tested whether adding a drug called pevonedistat to the standard two-drug combination (venetoclax and azacitidine) helps adults recently diagnosed with acute myeloid leukemia (AML) who are too frail for intensive chemotherapy. About 164 participants received either the…
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Head-to-Head: which biologic works better for tough psoriatic arthritis?
Disease control CompletedThis study tested two biologic drugs, secukinumab and ustekinumab, in 119 adults with active psoriatic arthritis who had not responded to or could not tolerate TNFα-inhibitor treatment. The main goal was to see which drug better improved physical function over 28 weeks. Researche…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug shows promise for cortisol disorder
Disease control CompletedThis study tested an experimental drug called SPI-62 in 26 adults with Cushing's syndrome caused by a non-adrenal tumor. The goal was to see if SPI-62 could lower cortisol levels safely. Participants received either SPI-62 or a placebo for 24 weeks, with an option to continue lon…
Phase 2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New combo therapy shows promise in leukemia battle
Disease control CompletedThis study tested whether adding a second drug (pegylated interferon) to the standard leukemia medication nilotinib helps people with newly diagnosed chronic myeloid leukemia (CML) achieve a deeper molecular response faster. About 200 adults under 65 with early-stage CML took par…
Phase 3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Lupus patients get extra nurse support to cut hospital visits
Disease control CompletedThis study tested a nurse-led care management program for lupus patients at high risk of missing appointments or ending up in the emergency room. Nurses received special training on lupus and social barriers to care, then reached out to patients to help them attend rheumatology v…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could your own fat cells tame rheumatoid arthritis?
Disease control CompletedThis early-phase trial tested a single infusion of stem cells taken from the patient's own belly fat in 15 adults with active rheumatoid arthritis. The main goal was to see if the treatment is safe over 12 months. Researchers also looked at whether it could lower inflammation mar…
Phase 1/2 • Sponsor: Hope Biosciences LLC • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Robot arm aims to make bone procedures safer and more precise
Disease control CompletedThis study tested a robotic system called EPIONE that helps doctors guide needles into bones during CT scans. The robot is used for procedures like biopsies, tumor treatments, and bone repairs. Researchers wanted to see if the robot could make these procedures safer and more accu…
Sponsor: Quantum Surgical • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New pill shows promise for Tough-to-Treat psoriatic arthritis
Disease control CompletedThis phase 3 study tested upadacitinib, an oral anti-inflammatory drug, in 642 adults with active psoriatic arthritis who had not responded well to at least one biologic treatment. Participants received either 15 mg or 30 mg of upadacitinib daily or a placebo. The main goal was t…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 26, 2026 16:42 UTC
-
Could a chemo combo save lungs in scleroderma patients?
Disease control CompletedThis study tested whether a combination of the chemotherapy drug cyclophosphamide and the steroid prednisone could help people with scleroderma-related lung disease. Forty adults whose lung function had worsened in the past year received either the drug combo or a placebo plus pr…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 16:08 UTC
-
Drug shows promise for kids with Arthritis-Related eye disease
Disease control CompletedThis study tested the drug adalimumab against a placebo in 34 children with juvenile arthritis and active eye inflammation (uveitis) that wasn't controlled by steroid drops or methotrexate. The goal was to see if adalimumab could reduce eye inflammation after two months. After th…
Phase 2/3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 14:26 UTC
-
Esmya under the microscope: is Long-Term use safe for fibroids?
Disease control CompletedThis study followed over 1,500 women with moderate to severe uterine fibroids who were taking Esmya (ulipristal acetate) long-term. Researchers tracked side effects, especially those affecting the uterus, and how doctors prescribed the drug in everyday practice. The goal was to b…
Sponsor: PregLem SA • Aim: Disease control
Last updated Jun 26, 2026 13:15 UTC
-
Bag it up: new device aims to make fibroid surgery safer
Disease control CompletedThis study tested whether using a special bag during laparoscopic fibroid removal (myomectomy or hysterectomy) can prevent the spread of cells that might be cancerous. Forty-eight women were randomly assigned to have the procedure with or without the bag. Researchers then checked…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 12:48 UTC
-
Ultrasound stiffness scans put tendon pain under the microscope
Diagnosis CompletedResearchers at Emory University are testing whether shear wave elastography, an ultrasound technique that measures tissue stiffness, can tell the difference between healthy tendons and painful ones. The study enrolls about 56 people, some with tendinopathy and some without, and s…
Sponsor: Emory University • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
New imaging tests aim to pinpoint the source of mysterious muscle pain
Diagnosis CompletedThis study is working to create a reliable imaging test to find and measure problem areas in muscle and fascia tissue, known as myofascial pain. Researchers will use ultrasound and MRI to identify unique 'biosignatures' in 120 people with plantar fasciitis, Achilles tendinopathy,…
Sponsor: Ruth Chimenti • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New 25-Minute bone scan could spot cancer faster with less radiation
Diagnosis CompletedThis study tested a new 3D bone scan camera (VERITON-CT) that takes only 25 minutes and uses less radiation than standard scans. Researchers compared it to conventional 2D scans in 146 people with suspected or known bone metastases. The goal was to see if the new method could acc…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
New imaging tool could help spot cancerous bone tumors earlier
Diagnosis CompletedThis study tested a new structured reporting system called BTI-RADS to help doctors better assess bone tumors from X-rays, CT, and MRI scans. Researchers analyzed images from 1,100 patients to see if the tool could more accurately tell which tumors are likely cancerous. The goal …
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Radiation-Free lung MRI could change how we diagnose scarring lung disease
Diagnosis CompletedThis study tested whether a special lung MRI can replace CT scans for diagnosing idiopathic pulmonary fibrosis (IPF), a scarring lung disease. Researchers compared MRI to standard CT in 60 patients to see if MRI could spot the same key signs of IPF without using radiation. The go…
Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
MRI may replace needle biopsy for muscle disease diagnosis
Diagnosis CompletedThis study looked at whether whole body MRI can accurately diagnose inflammatory myopathies—a group of muscle diseases causing weakness and damage. Researchers compared MRI results with muscle biopsies in 139 people suspected of having these conditions. If MRI proves reliable, it…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Ultrasound could spot deadly lung disease in scleroderma patients early
Diagnosis CompletedThis study tested whether a painless, non-radiation ultrasound of the chest can find early signs of lung scarring in people with scleroderma. Thirty patients without known lung disease on CT scans underwent thoracic ultrasound. The goal was to see how often ultrasound detects hid…
Sponsor: University Hospital, Tours • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Can a drug and donor cells stop leukemia from returning after transplant?
Prevention CompletedResearchers are testing whether giving azacitidine, a chemotherapy drug, together with donor lymphocyte infusions after a stem cell transplant can prevent relapse in people with high-risk acute myeloid leukemia or myelodysplastic syndrome. About 30 patients will receive the combi…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
Lupus drug hydroxychloroquine tested as COVID-19 shield
Prevention CompletedThis completed study looked at whether lupus patients already taking hydroxychloroquine long-term had a lower risk of catching COVID-19 or developing severe symptoms. Researchers compared 552 patients who either took the drug or did not, using blood tests and questionnaires. The …
Sponsor: University Hospital, Toulouse • Aim: Prevention
Last updated Aug 12, 2026 00:00 UTC
-
Can a single antibiotic dose cut child mortality in niger?
Prevention CompletedThis trial tests whether giving azithromycin—a common antibiotic—twice a year to young children in Niger can reduce deaths. It compares giving the drug to all children aged 1-59 months versus only to infants 1-11 months, who are at highest risk. The study also checks how these ap…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Melatonin gel tested to help dental implants grip in infected sockets
Symptom relief CompletedResearchers are testing whether a topical melatonin gel helps dental implants stay stable when placed immediately into tooth sockets that had chronic infection. Sixty adults with non-restorable teeth and long-standing apical lesions will receive either standard implant placement …
Sponsor: Mansoura University • Aim: Symptom relief
Last updated Sep 21, 2026 15:00 UTC
-
Ancient cupping technique tested for back pain relief
Symptom relief CompletedThis study tested whether wet cupping therapy, an ancient practice where small cuts are made on the skin and cups are used to draw out a small amount of blood, can help people with ankylosing spondylitis, a type of arthritis that mainly affects the spine. Half of the 100 particip…
Sponsor: Karabuk University • Aim: Symptom relief
Last updated Sep 21, 2026 15:00 UTC
-
Can taekwondo kicks ease ankylosing spondylitis?
Symptom relief CompletedResearchers are testing whether a 12-week Taekwondo training program can help adults with ankylosing spondylitis and axial spondyloarthritis. The trial enrolls 21 adults aged 19 to 59 who have stable treatment or no medication for at least three months. Participants join either a…
Sponsor: Wonju Severance Christian Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New injection may ease shoulder pain without surgery
Symptom relief CompletedThis study tests whether adding an injection called Tropho Tend to standard physical therapy helps reduce pain and improve shoulder function in people with rotator cuff tendinopathy. Sixty adults with shoulder pain lasting at least six weeks will be randomly assigned to receive e…
Sponsor: Mastelli S.r.l • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Which pain block works best for Kids' thigh surgery?
Symptom relief CompletedThis trial compares two ultrasound-guided pain-relief techniques for children aged 1 to 12 undergoing surgery on the front or side of the thigh. One group receives a fascia iliaca nerve block, while the other gets caudal analgesia, both given after general anesthesia. The goal is…
Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Tape or stretch? trial tests two ways to ease heel pain
Symptom relief CompletedPlantar fasciitis causes heel pain from irritation of the thick band of tissue on the bottom of the foot. This trial compares two common treatments: kinesiotaping, where a flexible tape is applied to the foot, and lower limb stretching exercises that target the calf and hamstring…
Sponsor: Health Education Research Foundation (HERF) • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a Calcium-Binding chemical melt away painful shoulder deposits?
Symptom relief CompletedCalcific tendinitis of the rotator cuff causes long-lasting shoulder pain when calcium builds up in the tendon. Standard treatment flushes the deposit with fluid, but the calcium often dissolves slowly. Researchers are testing whether injecting sodium thiosulfate, a chemical that…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Shoulder procedure: is the steroid shot necessary?
Symptom relief CompletedCalcific tendinitis of the rotator cuff causes long-lasting shoulder pain when calcium builds up in a tendon. A common treatment is ultrasound-guided needling and lavage to break up and flush out the deposit, often followed by a corticosteroid injection to prevent a pain flare. R…
Phase 4 • Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Steroid shot vs electrical nerve stimulation: which eases biceps tendon pain?
Symptom relief CompletedResearchers compare two treatments for long head of the biceps brachii tendinopathy, a common cause of shoulder pain. One group receives a single ultrasound-guided injection of triamcinolone acetonide and lidocaine around the tendon. The other group receives transcutaneous electr…
Sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Can a 12-Week exercise programme build strength safely in boys with hemophilia?
Symptom relief CompletedBoys with hemophilia often miss out on games and activities because of concerns about bleeding and joint damage. Researchers developed a 12-week muscle-strengthening exercise programme with input from children, parents, and physiotherapists. The DOLPHIN-II trial compares this pro…
Sponsor: East Kent Hospitals University NHS Foundation Trust • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Zapping a heel nerve: new hope for chronic foot pain?
Symptom relief CompletedThis small pilot study is testing whether using heat (radiofrequency ablation) to disable a nerve in the heel can relieve chronic pain from plantar fasciitis or heel spurs. The 31 participants have had pain for over 6 months and tried at least four other treatments without succes…
Sponsor: Şahide Eda Artuç • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Custom masks could help kids breathe easier at night
Symptom relief CompletedThis study tests whether custom-made 3D-printed masks fit children better than standard commercial masks for non-invasive ventilation (NIV). Fifteen children aged 8-12 who already use NIV but have poor adherence will try a custom mask made from a 3D facial scan. Researchers will …
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can AML patients give their own transfusions at home?
Symptom relief CompletedResearchers at Rigshospitalet in Denmark are testing whether adults newly diagnosed with acute myeloid leukemia can safely measure their own blood counts and give themselves blood and platelet transfusions at home. The study trains and certifies 22 participants to use a home bloo…
Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Five-minute video may ease tough choices for fibroid patients
Symptom relief CompletedThis study tests whether a 5-minute educational video about uterine fibroids and their treatments can help patients feel less conflicted when deciding on a treatment plan. About 154 women with fibroids will be randomly assigned to watch the video before their appointment or recei…
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Online course aims to give women tools to tame bladder pain
Symptom relief CompletedResearchers are testing a six-week online program called Learning to THRIVE for women with interstitial cystitis, also known as bladder pain syndrome. The program combines self-paced online lessons with weekly live virtual group meetings to teach pain management, self-care, commu…
Sponsor: University of Indianapolis • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can 3D-Printed insoles beat milled ones for heel pain?
Symptom relief CompletedThis trial tests two types of custom-made insoles for people with plantar fasciitis, a common cause of heel pain. One insole is milled from EVA foam, the other is 3D-printed from TPU plastic. Over 12 weeks, researchers measure calf muscle activity during walking, foot pressure, p…
Sponsor: Medipol University • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Can talk therapy plus exercise beat arthritis fatigue?
Symptom relief CompletedThis trial tests a new 24-week program called COMFI that combines a cognitive behavioral approach with physical activity to help people with inflammatory arthritis manage fatigue. Participants attend group sessions, an optional individual session, and a booster session, and they …
Sponsor: The Danish Center for Expertise in Rheumatology • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Shoulder surgery without the OR? new study tests In-Office biceps tenotomy
Symptom relief CompletedThis study tests if a biceps tendon cutting procedure (tenotomy) done in the doctor's office with a tiny camera and local anesthesia works as well as the same surgery in an operating room. 14 adults with shoulder pain from biceps or rotator cuff problems will be enrolled. The mai…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
A softer path to stronger muscles for arthritis?
Symptom relief CompletedThis study tests whether blood flow restriction training (BFRT) — using pressure cuffs during low-load exercise — can help people with rheumatoid or psoriatic arthritis build muscle with less joint strain than conventional strength training. Adults with these conditions will be r…
Sponsor: University of Bonn • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Which mouthguard do patients prefer for jaw pain?
Symptom relief CompletedThis study looked at how satisfied people were with three different types of mouthguards (occlusal splints) for jaw joint and muscle pain (TMD). 27 adults who had jaw pain for at least 3 months and had never been treated for it tried one of the splints. The main goal was to see w…
Sponsor: Mansoura University • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Dancing away arthritis: could tango boost daily activity?
Symptom relief CompletedThis study tests whether learning Argentine tango can increase overall physical activity in people with chronic inflammatory arthritis, such as rheumatoid arthritis or spondyloarthritis. Participants will take tango sessions that focus on body awareness, movement, and connection …
Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Targeted eccentric exercise may rebuild shoulder function — a trial puts it to the test
Symptom relief CompletedThis trial investigates whether eccentric isokinetic exercise — a type of controlled, lengthening muscle contraction performed on a special machine — can reduce pain and improve shoulder function in people with rotator cuff tendinopathy. Fifty adults aged 20 to 50 with confirmed …
Sponsor: Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Shock waves vs needle lavage: which eases shoulder pain best?
Symptom relief CompletedThis study compared two procedures for treating painful calcium buildup in the shoulder: barbotage (a needle-guided washout) and shock wave therapy. Sixty-three adults aged 30–60 with chronic shoulder pain were randomly assigned to one treatment. Researchers tracked pain levels a…
Sponsor: Maimónides Biomedical Research Institute of Córdoba • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Sound waves aim to soothe stubborn heel pain
Symptom relief CompletedThis trial investigates whether histotripsy, a focused ultrasound technique, can reduce pain in people with plantar fasciitis that has not responded to standard treatments like shock waves, orthotics, or steroid injections. Participants receive two ultrasound sessions and report …
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Can a fitness tracker and coaching get teens with leukemia moving?
Symptom relief CompletedThis study tested whether a mobile health program—including a Fitbit with movement reminders, coaching sessions, and a WhatsApp peer support group—could help 20 adolescents and young adults with acute lymphoblastic leukemia (ALL) reduce the time they spend sitting or lying down d…
Sponsor: Children's Hospital Los Angeles • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Nerve gliding exercises may amplify shock wave therapy for stubborn heel pain
Symptom relief CompletedThis study tests whether adding neural gliding exercises—gentle movements that help nerves slide smoothly—to standard shock wave therapy and home exercises can further reduce pain and improve foot function in people with plantar fasciitis. About 56 adults with this common cause o…
Sponsor: Ankara Yildirim Beyazıt University • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Laser or ultrasound: which zaps heel pain best?
Symptom relief CompletedThis study tested two device-based treatments—high-intensity laser and high-power ultrasound—against standard care for plantar fasciitis. 51 adults with heel pain for at least a month received one of the therapies three times a week for a month. Researchers measured pain levels a…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Nurse sessions may help arthritis patients handle biologic drugs safely
Symptom relief CompletedThis study tested whether nurse-led consultations can help people with rheumatoid arthritis become more independent in managing their subcutaneous biotherapy. Many patients struggle to recognize warning signs and delay seeking help. The study enrolled 71 adults with rheumatoid ar…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Ancient chinese practice tested to ease lupus fatigue and stress
Symptom relief CompletedThis study tested whether practicing Qi Gong, a gentle mind-body exercise, could improve quality of life in people with systemic lupus erythematosus (SLE). Thirty-three participants took part in weekly Qi Gong sessions for six months. Researchers measured changes in physical func…
Sponsor: University Hospital, Limoges • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Ear stimulation device shows promise for Ehlers-Danlos relief
Symptom relief CompletedThis study tested whether a small, at-home device that stimulates a nerve in the ear can improve symptoms like pain, fatigue, sleep, and mood in people with hypermobile Ehlers-Danlos syndrome (hEDS). Twenty-five adults with hEDS used the device daily for two weeks, with some rece…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Heel pain showdown: gentle touch vs. tennis ball – which eases plantar fasciitis best?
Symptom relief CompletedThis study tested two simple, non-invasive treatments for plantar fasciitis, a common cause of heel pain. Eighty adults aged 20–50 with heel pain lasting over 4 weeks were split into two groups: one received Bowen therapy (a gentle hands-on technique) twice weekly for 12 weeks, w…
Sponsor: Green International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can mindfulness ease arthritis pain? small study seeks answers
Symptom relief CompletedThis completed pilot study tested an 8-week online mindfulness course in 38 people with rheumatoid arthritis. The goal was to see if patients liked the program, what barriers they faced, and how it might affect symptoms. Half the group took the course while the other half receive…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Taping or no taping? new study tests best way to soothe heel spur pain
Symptom relief CompletedThis study tested two physical therapy approaches for people with painful heel spurs. 38 adults received either myofascial release alone or myofascial release plus taping over several weeks. The goal was to see which method better reduces pain and improves foot function. Results …
Sponsor: Green International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Could a dab of antibiotic gel replace pills after wisdom tooth removal?
Symptom relief CompletedThis study tested whether applying antibiotics directly into the tooth socket after wisdom tooth removal works as well as taking antibiotic pills. 90 adults having their lower wisdom teeth taken out were split into two groups: one got antibiotic gel at the surgery site, the other…
Phase 4 • Sponsor: Liaquat College of Medicine and Dentistry • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Vitamin cocktail may shrink fibroids, reduce surgery need
Symptom relief CompletedThis study tested a 3-month treatment with a combination of vitamin D, green tea extract (EGCG), vitamin B6, and D-Chiro-inositol in 108 women with uterine fibroids who were planning surgery. The goal was to see if the supplement could ease symptoms and possibly help some women a…
Sponsor: Universita di Verona • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Home workouts for scleroderma lungs show promise in small pilot study
Symptom relief CompletedThis study tested whether a personalized home respiratory rehabilitation program is feasible for people with systemic sclerosis (scleroderma) who have early lung disease. Fifteen participants completed a 3-month program with one supervised session followed by home exercises. The …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Cancer drug repurposed to fight rare skin disease in small safety trial
Symptom relief CompletedThis early-phase study tested whether a drug used for lymphoma, brentuximab vedotin, is safe for people with a severe form of scleroderma (diffuse cutaneous systemic sclerosis). The drug targets overactive immune cells that may drive the disease. Only 17 people took part, and the…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Heel pain showdown: surgery or exercise for plantar fasciitis?
Symptom relief CompletedThis study tested whether surgery (radiofrequency microtenotomy) or non-surgical treatment (strength training) works better for chronic plantar fasciitis—a common cause of heel pain. 70 adults with heel pain lasting over 7 months took part. The main goal was to see which approach…
Sponsor: University of Southern Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Can an app beat fatigue in scleroderma? small study tests feasibility
Symptom relief CompletedThis study tested a smartphone app called RENEW designed to help people with scleroderma manage fatigue and build resilience. Over 12 weeks, 43 participants used the app to set and track weekly healthy goals. The main goal was to see if people would actually use the app and compl…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New device AVELI tackles cellulite and fibrosis in liposuction patients
Symptom relief CompletedThis study tested a device called AVELI to safely reduce cellulite and fibrous tissue in 130 people undergoing body contouring surgery. Researchers measured safety, patient satisfaction, and appearance improvements over 9 months. The goal was to see if adding AVELI to standard li…
Sponsor: Total Definer Research Group • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Can a common Alzheimer's drug clear lupus brain fog?
Symptom relief CompletedThis study tested whether memantine, a drug used for Alzheimer's, can help with thinking and memory problems in people with lupus. About 111 adults with lupus and cognitive issues took either memantine or a placebo for 14 weeks. The goal was to see if the drug safely improves bra…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a Stress-Management program help young cancer patients cope?
Symptom relief CompletedThis study tested whether a program called PRISM (Promoting Resilience in Stress Management) could help young adults aged 18-39 who have cancer or desmoid tumors manage anxiety and depression. The program teaches skills like stress management, goal setting, and positive thinking.…
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Dietary formula shows promise for psoriatic arthritis symptom relief
Symptom relief CompletedThis study tested whether a food formula containing medium-chain triglycerides (MCTs) and vegetable fibers could improve quality of life in 72 adults with psoriatic arthritis and low disease activity. Participants took the formula for 3 months while continuing their usual medicat…
Sponsor: Dr. Schär AG / SPA • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
New vaginal surgery technique may reduce pain after hysterectomy
Symptom relief CompletedThis study compared two types of minimally invasive hysterectomy: vNOTES (done through the vagina) and conventional laparoscopic hysterectomy (done through small belly cuts). About 90 women having hysterectomy for non-cancer reasons took part. The goal was to see which method cau…
Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Step by step: walking program shows promise for lupus fatigue
Symptom relief CompletedThis study tested whether a simple walking program using a pedometer could help reduce fatigue and improve quality of life in people with lupus. 101 participants were randomly assigned to either a walking group with personalized step goals or a wait-list control group. The progra…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Can a smartphone app ease rheumatoid arthritis symptoms?
Symptom relief CompletedThis study tested a mobile app designed to help people with rheumatoid arthritis manage their condition. 90 adults with stable treatment used the app for 12 weeks, while a control group received usual care. Researchers measured changes in disease activity and quality of life to s…
Sponsor: Kırıkkale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Laser zaps face veins in scleroderma patients – 21 test it out
Symptom relief CompletedThis study tested a pulsed dye laser to reduce red veins (telangiectasias) on the face and neck in 21 people with scleroderma. Participants received four laser sessions, and the researchers checked how many veins disappeared, how patients felt about the results, and any side effe…
Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Acupuncture before surgery may steady blood pressure in hysterectomy patients
Symptom relief CompletedThis small pilot study looked at whether acupuncture given twice before surgery could help stabilize blood pressure in women having their uterus removed (total laparoscopic hysterectomy) for fibroids. Thirty-five adult patients received acupuncture before the operation, and resea…
Sponsor: Ilsan Cha hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Foam rolling or special tools: which eases heel pain best?
Symptom relief CompletedThis study tested two hands-on treatments for chronic plantar fasciitis, a common cause of heel pain. Fifty-six adults received either instrument-assisted soft tissue mobilization or foam rolling, plus exercises. The goal was to see which approach better reduces pain, improves an…
Sponsor: Manav Rachna International Institute of Research and Studies • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New study examines pain and adherence in patients switching to concentrated adalimumab
Symptom relief CompletedThis study involved 324 adults with conditions like Crohn's disease, arthritis, or psoriasis who switched from a standard to a higher-concentration form of adalimumab (AVT-02). Researchers measured injection site pain and how well patients stuck with their treatment over 180 days…
Sponsor: Jamp Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New study: shoulder surgery helps older cancer patients move better and hurt less
Symptom relief CompletedThis study looked at 53 patients with cancer that spread to the upper arm bone, causing pain and limited movement. Researchers compared older and younger patients who had shoulder replacement surgery to see if age affected recovery. The goal was to find out if this surgery is saf…
Sponsor: Sichuan Provincial People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Rehab program shows promise for scleroderma Patients' daily life
Symptom relief CompletedThis study tested whether a personalized rehabilitation program could improve quality of life for people with systemic sclerosis, a disease that causes skin and joint stiffness. 220 adults with the condition were randomly assigned to either the rehab program or usual care. The pr…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can your own blood soothe dry eyes? new study says maybe.
Symptom relief CompletedThis study tested whether eye drops made from a patient's own blood (autologous serum) can relieve severe dry eye better than standard artificial tears. 46 adults with severe dry eye tried both diluted (20%) and full-strength (100%) serum drops, as well as artificial tears. The m…
Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Remote Check-Ins may ease psoriatic arthritis symptoms
Symptom relief CompletedThis study tested whether two structured telemedicine visits, added between regular doctor appointments, could help people with psoriatic arthritis improve their quality of life and reduce disease impact. 101 adults with active symptoms took part. The visits focused on lifestyle …
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
App + fitbit helps arthritis patients take control
Symptom relief CompletedThis study tested a program called OPERAS that includes a web app for tracking symptoms and a physiotherapist who gives activity advice using a Fitbit. The goal was to see if it helps people with rheumatoid arthritis feel more confident managing their disease. 132 adults with rhe…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Herbal remedy tested for lupus fatigue in small trial
Symptom relief CompletedThis study tested whether an herbal supplement could reduce fatigue in people with lupus. 59 adults with lupus and significant tiredness took either the supplement or a placebo for 8 weeks. The main goal was to see if fatigue and disease activity improved. The results may offer a…
Sponsor: University Tunis El Manar • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Exercise program shows promise for marfan syndrome patients
Symptom relief CompletedThis study tested a personalized exercise program for 28 children and young adults with Marfan syndrome, a rare genetic condition affecting the heart, eyes, and bones. The program aimed to improve endurance, muscle strength, and quality of life. Researchers measured changes in fi…
Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Nerve block eases Post-Surgery insomnia and anxiety in women
Symptom relief CompletedThis study tested whether a nerve block (stellate ganglion block) combined with standard anesthesia could help women with uterine fibroids sleep better and feel less anxious after laparoscopic surgery. 233 women aged 35-55 took part. Results aim to show if this approach reduces s…
Sponsor: Xiaochen Ji • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New drug could ease stubborn shoulder pain
Symptom relief CompletedThis study tested whether secukinumab, an anti-inflammatory drug, can reduce pain and improve function in adults with moderate to severe rotator cuff tendinopathy (shoulder tendon pain) that didn't get better with standard treatments. 62 participants received either the drug or a…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Free blood transfusions help blood cancer patients choose hospice
Symptom relief CompletedThis study looked at whether providing free blood transfusions to blood cancer patients would encourage them to enroll in hospice care earlier. Many patients delay hospice because they need transfusions for symptom relief, but hospices often cannot afford to provide them. The stu…
Sponsor: Adam Olszewski • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Can a depression drug ease bladder pain? new study investigates
Symptom relief CompletedThis study tested whether amitriptyline, a drug already used for depression and some chronic pain conditions, can relieve symptoms of painful bladder syndrome (PBS) in people newly diagnosed with the condition. PBS causes frequent urination and increasing pain as the bladder fill…
Phase 3 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Bladder gel shows promise for chronic pelvic pain in women
Symptom relief CompletedThis study tested a gel called Cystistat (sodium hyaluronate) placed directly into the bladder to treat women with interstitial cystitis, a condition causing long-term bladder pain. Researchers tracked 74 women to see if the gel improved their symptoms and was safe. The goal was …
Sponsor: MEDA Pharma GmbH & Co. KG • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Chair yoga may ease scleroderma symptoms, small study hints
Symptom relief CompletedThis pilot study tested whether gentle yoga and breathing exercises are feasible for people with scleroderma, a condition that can limit movement. Thirty participants learned chair-based yoga and breathing techniques, then practiced twice daily at home for 10 weeks. Researchers m…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Steroid injection during fibroid procedure may ease Post-Op pain
Symptom relief CompletedThis study tested whether giving an anti-inflammatory steroid directly into the uterine arteries during a non-surgical fibroid treatment can lessen pain, nausea, vomiting, and tiredness afterward. Forty-two women with symptomatic fibroids took part. The goal was to see if this si…
Phase 3 • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Numbing shots before fibroid surgery may ease Post-Op pain
Symptom relief CompletedThis study tested whether injecting the numbing drug ropivacaine into the belly and around a nerve cluster before surgery can lower pain after laparoscopic fibroid removal. 207 women having fibroid surgery were randomly assigned to get either ropivacaine or a placebo. The main go…
Sponsor: Saint Petersburg State University, Russia • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Laser showdown: which technique eases heel pain best?
Symptom relief CompletedThis study tested two ways of using high-intensity laser therapy to relieve pain from plantar fasciitis, a common cause of heel pain. 24 adults with the condition received either a static (pointed) or scanning (sweeping) laser application. Researchers measured pain levels and fas…
Sponsor: University of Seville • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Can a fentanyl spray stop pain during cancer radiation?
Symptom relief CompletedThis completed Phase 3 trial tested whether a fentanyl spray (Pecfent) could prevent pain when moving patients with bone metastases during radiotherapy. 39 adults with cancer that spread to bone and who had pain during positioning for radiation took part. The study compared fenta…
Phase 3 • Sponsor: Centre Henri Becquerel • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Stress-Busting program tested for lupus patients
Symptom relief CompletedThis study tested a 6-week stress management program for 30 African American adults with lupus. Half took part in group sessions while the other half received usual care. Researchers measured stress levels, saliva stress hormones, and quality of life to see if the program helped.
Phase 1/2 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Which painkiller works best after shoulder surgery? new study compares options
Symptom relief CompletedThis study looked at adding tramadol, nefopam, or opioids to standard painkillers (paracetamol and ketoprofene) for adults recovering from shoulder surgery. 92 patients were enrolled, and their recovery quality was measured using a survey. The goal was to find the best oral pain …
Phase 4 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Lupus Self-Help program tested in african american women
Symptom relief CompletedThis study tested whether a 6-week self-management workshop, called the Chronic Disease Self-Management Program, could improve health and reduce healthcare use in African American women with lupus. Nearly 700 women from the GOAL study took part. The program covers topics like dea…
Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New anesthesia mix may ease pain after hand surgery
Symptom relief CompletedThis study tested two local anesthesia methods for hand, wrist, or elbow surgery. One used lidocaine alone, the other added ropivacaine for longer pain relief. 91 adults participated. Researchers measured pain and recovery quality 48 hours after surgery to see if the combination …
Phase 1 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Exercise eases stiffness in ankylosing spondylitis patients
Symptom relief CompletedThis study tested whether a 9-week personalized physical training program using an exercise bike could help people with ankylosing spondylitis, a type of arthritis that affects the spine. Fifty-six patients participated, and researchers measured how many achieved a meaningful imp…
Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Itch relief showdown: which drug stops water-induced agony?
Symptom relief CompletedThis study tested two oral medications, aprepitant and hydroxyzine, to see which better reduces severe itching triggered by water contact in people with myeloproliferative neoplasms (a type of blood cancer). 63 participants who had persistent itching rated 5 or higher on a 10-poi…
Phase 3 • Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Supplements before fibroid surgery show promise in small study
Symptom relief CompletedThis pilot study tested whether taking a combination of EGCG (from green tea), vitamin D, and D-chiro-inositol for three months before hysteroscopic myomectomy improves surgical outcomes. 90 women with uterine fibroids were divided into two groups: one received the supplements be…
Sponsor: Centro di Ricerca Clinica Salentino • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New device zaps spine tumor pain in clinical trial
Symptom relief CompletedThis study tested a new device called Spinery® that uses radio-frequency energy to treat painful tumors that have spread to the spine or nearby bones. 52 adults who could not have or did not benefit from standard treatments received the procedure. The goal was to see if the devic…
Sponsor: Axon srl • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Tape it better? small study tests kinesiologic taping for knee arthritis pain
Symptom relief CompletedThis completed trial tested whether kinesiologic taping (a special elastic tape) applied to the knee can reduce pain, improve mobility, and lessen fear of movement in people with rheumatoid arthritis. Thirty adults aged 45 to 60 were randomly assigned to receive either real kines…
Sponsor: Istanbul Rumeli University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Electric needle therapy shows promise for foot pain
Symptom relief CompletedThis study tested whether a procedure called percutaneous needle electrolysis can help people with posterior tibial tendinopathy, a common cause of foot pain. 46 adults with pain for at least 3 months were split into two groups to compare the treatment against a control. Research…
Sponsor: Universidad Rey Juan Carlos • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New online program eases Kids' cancer return to school
Symptom relief CompletedThis study tested a web-based program to help children aged 8-17 with cancer adjust to returning to school. The program included modules for children, parents, teachers, and peers, focusing on communication, coping, and social skills. Twenty children participated, and researchers…
Sponsor: Gazi University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New combo treatment tackles heel pain that Won't go away
Symptom relief CompletedThis pilot study tested a procedure that combines a needle tenotomy (breaking up scar tissue with a needle) with an injection of platelet-rich plasma (PRP) for people with chronic plantar fasciitis that didn't improve with standard treatments like physical therapy or steroid shot…
Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 17:36 UTC
-
Can early palliative care ease suffering in relapsed leukemia?
Symptom relief CompletedThis study looked at whether early, regular visits from a palliative care team can improve quality of life for adults with acute leukemia that has returned. 49 patients were assigned to either receive this extra support or standard care. The team addressed physical, emotional, an…
Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 26, 2026 16:57 UTC
-
Can blood markers predict how MS affects walking and thinking?
Knowledge-focused CompletedResearchers are studying whether certain immune substances in the blood are linked to physical and mental abilities in people with relapsing-remitting multiple sclerosis. The study includes 20 adults aged 19 to 45 with mild disability. Participants give blood samples, and researc…
Sponsor: Halic University • Aim: Knowledge-focused
Last updated Sep 21, 2026 15:00 UTC
-
New study aims to crack the code of autoimmune diseases
Knowledge-focused CompletedThis study is collecting blood, urine, and stool samples from 500 children with autoimmune diseases and healthy controls. Researchers will analyze these samples to find molecular patterns that could help diagnose these conditions and guide treatment decisions. The goal is to crea…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
COVID-19's hidden toll on autoimmune patients revealed
Knowledge-focused CompletedThis study followed 293 people with autoimmune diseases and healthy volunteers to see how COVID-19 infection or vaccination affects their immune system, inflammation, and blood vessels. Participants were grouped based on their COVID-19 history and had up to 5 visits over 12-18 mo…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Military myositis mystery: could exposures be the trigger?
Knowledge-focused CompletedThis study investigated whether environmental exposures during military service increase the risk of developing myositis, a rare autoimmune disease that attacks muscles. Researchers compared 37 military personnel with and without myositis using questionnaires and blood samples. N…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a blood marker reveal how rehabilitation affects axial spondyloarthritis?
Knowledge-focused CompletedResearchers at Giresun University are studying whether a blood protein called calprotectin changes in people with axial spondyloarthritis who complete a four-week pulmonary rehabilitation program. Thirty patients aged 25 to 65 will take part. The team will measure calprotectin al…
Sponsor: Giresun University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches major study to unlock secrets of rare inflammatory diseases
Knowledge-focused CompletedThis study follows up to 5,000 people with autoinflammatory diseases (like NOMID, CANDLE, and juvenile dermatomyositis) and their healthy relatives. Researchers will collect medical history, blood samples, and imaging over 2-5 day visits to learn how these diseases work and find …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Hidden gut inflammation may drive familial mediterranean fever
Knowledge-focused CompletedResearchers are studying whether the lining of the small intestine shows signs of inflammation in people with Familial Mediterranean Fever (FMF), a genetic condition that causes recurring fevers and pain. The study compares intestinal biopsy samples from about 30 adults with FMF …
Sponsor: Hitit University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Scientists hunt for hidden triggers of autoimmune diseases
Knowledge-focused CompletedThis study collects tissue and blood samples from 300 people with autoimmune diseases like Crohn's, multiple sclerosis, and celiac disease. Researchers aim to identify the specific targets of immune cells (T cells) that cause inflammation. The goal is to discover new targets for …
Sponsor: TScan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
The immune cells that could make stem cell transplants work better
Knowledge-focused CompletedResearchers are studying natural killer (NK) cells in people who receive stem cell transplants for leukemia. The study follows 92 patients and their donors, looking at genes called KIR and HLA that control how NK cells work. By tracking NK cells during immune recovery, researcher…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Pens and vouchers: can small rewards boost participation in blood cancer research?
Knowledge-focused CompletedResearchers want to learn what causes myeloproliferative neoplasms, a group of rare blood cancers. They are testing whether small incentives like pens, trolley tokens, or a £10 reimbursement encourage more people to join a case-control study. The trial includes about 100 patients…
Sponsor: Queen's University, Belfast • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Leukemia treatment showdown: which works best?
Knowledge-focused CompletedThis registry study follows 400 patients with a specific type of leukemia (non-high-risk APL) who are 70 or younger. It compares two standard treatments: ATRA plus chemotherapy versus ATRA plus arsenic trioxide. The goal is to see which approach leads to better long-term outcomes…
Sponsor: Groupe Francophone des Myelodysplasies • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Scleroderma patients to decide: infographic vs. plain language for research results
Knowledge-focused CompletedThis study aims to find the best way to share research results with people who have scleroderma, a rare autoimmune disease. About 128 participants will be randomly assigned to receive either an infographic or a plain-language summary of a study. They will then rate how complete, …
Sponsor: Lady Davis Institute • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Twin study seeks clues to rheumatic disease mysteries
Knowledge-focused CompletedThis study looks at families where one sibling has a rheumatic disease (like rheumatoid arthritis or lupus) and the other does not. Researchers compare their blood, genes, and environmental exposures to find clues about why one got sick. Over 1,000 participants are involved, incl…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can a simple step test spot balance issues in arthritis patients?
Knowledge-focused CompletedThis study checks whether the Four Square Step Test (FSST) is a good way to measure balance in people with rheumatoid arthritis. Researchers will test 50 adults aged 18-65 with RA, comparing FSST results to other measures like disease activity, pain, and muscle strength. The goal…
Sponsor: Inonu University • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Scientists hunt for genetic and environmental triggers of rare muscle diseases
Knowledge-focused CompletedThis study looked at 719 people, including patients with autoimmune connective tissue diseases like myositis, their blood relatives, and healthy volunteers. Researchers collected blood samples and medical histories to find genetic and environmental factors that may trigger these …
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Farming exposures under the microscope: massive health study follows 90,000 participants
Knowledge-focused CompletedThis study follows nearly 90,000 farmers and their spouses to track long-term health effects of pesticides, crops, and animals. Participants report new medical conditions, which researchers then confirm through medical records and genetic samples. The goal is to better understand…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New program aims to improve pregnancy care for women with lupus
Knowledge-focused CompletedThis study tests a program called HOP-STEP that helps doctors talk about pregnancy planning with women who have lupus. The goal is to make sure doctors document contraception use and pregnancy intentions during visits. The study involves 14 participants and is being tested at two…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Are women with autoimmune diseases getting the gynecological care they need?
Knowledge-focused CompletedThis study examined whether women with autoimmune diseases or inflammatory rheumatism receive proper gynecological follow-up, including cervical cancer screening and contraception advice. Researchers surveyed 318 women with conditions like lupus, rheumatoid arthritis, and Sjögren…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Can group learning make biotherapy safer for arthritis patients?
Knowledge-focused CompletedThis trial investigates whether combining group and individual educational sessions helps patients with chronic inflammatory rheumatism (like rheumatoid arthritis or spondyloarthritis) learn safety skills better than individual sessions alone. Participants are starting their firs…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Can we break the vicious cycle of VEXAS syndrome?
Knowledge-focused CompletedThis study aims to understand how inflammation and the dominance of mutant blood cells drive VEXAS syndrome, a rare and severe autoinflammatory disease. Researchers will analyze blood and bone marrow samples from VEXAS patients and healthy controls to identify key mechanisms and …
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Smartphone videos could replace the doctor's joint exam for arthritis?
Knowledge-focused CompletedThis study tests whether a smartphone-based digital assessment can measure rheumatoid arthritis activity as well as a standard doctor-performed exam. Adults with rheumatoid arthritis will complete a digital questionnaire, record guided videos of their joint movements, and then ha…
Sponsor: Synovo Ltd. • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Lupus study tracks disease activity in over 600 patients
Knowledge-focused CompletedThis completed study looked at 621 people with moderate to severe systemic lupus erythematosus (SLE) in Russia. Researchers collected information about their disease activity and background to better understand the condition. The study did not test any new treatment, but aimed to…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
How hard should you press? study tests three force levels for a common muscle release technique
Knowledge-focused CompletedThis study tests three different force levels (2 kg, 5 kg, and 11 kg) of the 'crossed hands' myofascial release technique on healthy adults. The goal is to see how each force affects muscle stiffness, thickness, pain sensitivity, and lower back and hip mobility. By finding the mo…
Sponsor: Universidad de la Sabana • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Can flexible joints and flat feet worsen scoliosis? new study investigates
Knowledge-focused CompletedThis completed study examined 22 adolescents with idiopathic scoliosis to see if joint hypermobility (flexibility) and foot posture are linked to the severity of their spinal curve. Researchers measured hypermobility with the Beighton Score, foot posture with the Foot Posture Ind…
Sponsor: Istinye University • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Tiny study aims to predict lupus flares before they strike
Knowledge-focused CompletedThis completed study enrolled 6 adults with systemic lupus erythematosus (SLE) to collect blood, urine, saliva, stool, and tissue samples over time. The goal was to find biological markers that could predict when a patient's disease might flare up or how they might respond to tre…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Could a pneumonia drug boost leukemia treatment? small trial explores safety and dosing
Knowledge-focused CompletedThis early-phase trial tested whether adding atovaquone (a drug usually used to prevent pneumonia) to standard chemotherapy is safe and reaches effective levels in the blood. It involved 26 children and young adults (ages 1 month to 21 years) newly diagnosed with acute myeloid le…
Early phase 1 • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Real-World study tests whether aggressive early treatment improves psoriatic arthritis outcomes
Knowledge-focused CompletedThis study follows people newly diagnosed with psoriatic arthritis (PsA) to see how a 'treat to target' approach works in everyday clinics. Participants receive standard care, often starting with methotrexate, and their disease activity is tracked over time. The goal is to unders…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Immune cell study could pave way for new arthritis treatments
Knowledge-focused CompletedThis study looked at a type of immune cell called B regulatory cells in 100 people—some healthy and some with rheumatoid arthritis (RA). The goal was to understand how these cells differ between the two groups and how they might help control the disease. By identifying unique fea…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could natural immune cells help fight leukemia drug resistance?
Knowledge-focused CompletedThis completed study from France examined whether a specific type of immune cell (innate CD8+ T cells) is linked to how quickly resistance mutations develop in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia. Researchers analyzed blood…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can text messages help arthritis patients take their meds?
Knowledge-focused CompletedThis study looked at three ways to help people with rheumatoid arthritis take their methotrexate medication as prescribed: usual doctor visits, text message reminders, or a chat with a pharmacist. The goal was to see which method works best to improve adherence. The study include…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could low vitamin c explain lingering pain in rheumatism and lupus?
Knowledge-focused CompletedThis study looks at whether people with chronic inflammatory rheumatism (like spondyloarthritis) or lupus who still have pain despite treatment have low vitamin C levels. Researchers will measure vitamin C in the blood and ask about pain, fatigue, and quality of life. The goal is…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Lung clues could unlock early rheumatoid arthritis detection
Knowledge-focused CompletedThis completed study looked at 340 people to understand how certain proteins in the lungs, called autoantibodies, might be linked to the start of rheumatoid arthritis (RA). Researchers collected sputum (mucus from the lungs) from people at risk for RA, those already diagnosed, an…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New arthritis drug copy tested in healthy people
Knowledge-focused CompletedThis study tested whether a new version of the arthritis drug abatacept (called KSHB002) works similarly to the approved drug Orencia. Three hundred healthy adults received a single injection of either the new drug or Orencia. Researchers measured drug levels in the blood, checke…
Phase 1 • Sponsor: Kashiv BioSciences, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Wearable sensors could revolutionize how we track ankylosing spondylitis
Knowledge-focused CompletedThis study tested whether wearable motion sensors can accurately measure spinal movement in people with ankylosing spondylitis (AS), a condition that causes back pain and stiffness. Forty participants (20 with AS and 20 healthy volunteers) wore sensors while performing everyday m…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Scleroderma Patients' nutrition under the microscope
Knowledge-focused CompletedThis study followed 150 adults with systemic sclerosis (scleroderma) for two years to track their nutritional health. Researchers measured weight, diet, and disease severity every six months. If malnutrition was found, patients received dietary advice or supplements. The goal was…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Rheumatism Patients' COVID antibodies under the microscope
Knowledge-focused CompletedThis study followed 163 people with chronic inflammatory rheumatism (like rheumatoid arthritis) who had a recent COVID-19 infection. Researchers measured their antibody levels over two years to see how immunosuppressive drugs affect antibody persistence. The goal was to better un…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Study reveals how well saudi doctors follow safety rules for common arthritis drug
Knowledge-focused CompletedThis study looked at whether healthcare professionals in Saudi Arabia are aware of and follow safety measures for the drug leflunomide, used for rheumatoid and psoriatic arthritis. Researchers surveyed 302 doctors and pharmacists to see if they received and read safety materials,…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Can bone markers predict survival in lung cancer patients?
Knowledge-focused CompletedThis study enrolled 200 adults with lung adenocarcinoma that has spread to the bones. Researchers took bone biopsies, scans, and blood tests to measure bone and metabolic markers. The goal is to see if these markers are linked to how long patients live. This is an observational s…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Pandemic stress hits hard for arthritis patients
Knowledge-focused CompletedThis completed study looked at how the COVID-19 pandemic and social distancing impacted the mental health of 259 adults with chronic inflammatory rheumatism (like rheumatoid arthritis or ankylosing spondylitis). Researchers used questionnaires to measure stress, depression, anxie…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New shoulder pain guideline put to the test in GP clinics
Knowledge-focused CompletedThis study tested whether giving general practitioners a simple, evidence-based guideline improves care for people with shoulder pain. 160 adults with shoulder pain took part in Norwegian GP clinics. Researchers measured pain, disability, and quality of life to see if the guideli…
Sponsor: University of Oslo • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
New MRI technique reveals hidden details of the achilles tendon
Knowledge-focused CompletedThis study used a special MRI technique to create detailed maps of the Achilles tendon in 121 adults. Researchers compared healthy volunteers to people with a type of arthritis called spondyloarthropathy, both with and without tendon pain. The goal was to better understand tendon…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Stiffness check could boost fibroid treatment success
Knowledge-focused CompletedThis study looked at whether measuring the stiffness of uterine fibroids can help predict how well they respond to a non-invasive treatment called MR-HIFU. Forty women with symptomatic fibroids were enrolled. The goal was to improve patient selection so that only those likely to …
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Spinal fluid inflammation may explain tethered cord damage in kids
Knowledge-focused CompletedThis study examined spinal fluid from 32 children with tethered spinal cord to see if inflammation plays a role in the condition. Researchers collected fluid samples during surgery and looked for markers of inflammation. The goal was to better understand how the spinal cord gets …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
New ultrasound technique reveals how healed tendons perform after ACL repair
Knowledge-focused CompletedThis study looked at 29 people who had ACL surgery using their own hamstring tendons. Researchers used a special ultrasound to check how stretchy the healed tendons were and compared them to the healthy leg. They also tested leg muscle strength to see if tendon quality affects re…
Sponsor: Fatih Sultan Mehmet Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Blood markers may predict arthritis drug success
Knowledge-focused CompletedThis study aimed to find blood markers that can predict whether the drug adalimumab will successfully treat ankylosing spondylitis after 6 months. Researchers analyzed blood samples from 50 adults starting adalimumab for the first time. The goal was to create an algorithm to help…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Massive study reveals COVID-19 risks for autoimmune patients
Knowledge-focused CompletedThis study looked at over 13,000 people with chronic inflammatory rheumatism or autoimmune diseases who had or were suspected to have COVID-19. Researchers tracked how many developed severe COVID-19 requiring intensive care or leading to death. They also examined risk factors lik…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Tiny particles may hold clues to autoimmune diseases
Knowledge-focused CompletedThis study looked at tiny particles called microparticles in the blood and urine of people with lupus or scleroderma. Researchers wanted to see if these particles could help explain how these diseases work and possibly lead to better diagnosis or treatment. Over 200 adults partic…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Brain radiation may erase personal memories, study warns
Knowledge-focused CompletedThis study looks at how radiation therapy for brain tumors like meningioma or pituitary adenoma might affect autobiographical memory—the memories of your life events. Researchers will ask 17 patients to complete memory tests one and two years after treatment. The goal is to see i…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Lupus clue: can a heart drug reveal hidden disease markers?
Knowledge-focused CompletedThis small pilot study looked at whether clopidogrel, a drug that stops blood clots, could lower a substance called sCD40L in people with lupus. Lupus is an autoimmune disease where the body attacks itself. The study involved 18 adults with lupus and measured sCD40L levels in the…
Phase 1/2 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New study aims to predict which fibroids respond best to Non-Invasive ultrasound treatment
Knowledge-focused CompletedThis study looked at 40 women with symptomatic uterine fibroids to understand why MR-guided focused ultrasound (HIFU) works better for some than others. Researchers used MRI and contrast-enhanced ultrasound to measure fibroid blood flow, stiffness, and other features before treat…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Scientists probe Immune-Vessel link in rare scleroderma
Knowledge-focused CompletedThis study looked at how blood vessel cells and immune cells talk to each other in people with systemic sclerosis, a rare autoimmune disease that causes skin hardening and organ damage. Researchers collected blood samples and skin biopsies from 350 participants to measure a speci…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Could your diet trigger lupus? new study investigates
Knowledge-focused CompletedThis study measured phytoestrogens (plant-based compounds) in the blood and urine of 63 premenopausal women with active lupus, other autoimmune diseases, or no disease. Researchers also asked about diet and measured estradiol levels. The goal was to see if these dietary compounds…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Lupus skin study reveals why patients skip meds
Knowledge-focused CompletedThis study looked at 202 adults with cutaneous lupus to see how well they follow their treatment plans and how satisfied they are with their care. Researchers used questionnaires to measure adherence, beliefs about medicine, anxiety, depression, and quality of life. The goal is t…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Can a simple blood test help rheumatoid arthritis patients get the right drug?
Knowledge-focused CompletedThis study looked at whether measuring drug levels and anti-drug antibodies in the blood of rheumatoid arthritis patients can help doctors make better treatment decisions. 52 patients starting adalimumab or certolizumab were randomly assigned to have their test results shared wit…
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Scientists analyze genetic markers in stored samples to boost personalized medicine
Knowledge-focused CompletedThis study looked at DNA methylation patterns in stored samples from 90 patients with rare skeletal disorders, sarcomas, or inflammatory arthritis. The goal was to better understand these patterns and explore their potential for diagnosis and treatment. The research aimed to impr…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Blood sample study explores new target for inflammatory arthritis
Knowledge-focused CompletedThis study looked at blood samples from 24 people with axial spondyloarthritis (a type of inflammatory arthritis) and 12 healthy volunteers to understand how a receptor called KIR3DL2 contributes to inflammation. Researchers also tested whether a drug called IPH4102 could reduce …
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Study reveals hidden toll of skin changes in rare disease
Knowledge-focused CompletedThis study looked at how skin changes from systemic sclerosis affect a person's feelings about their appearance. Researchers compared 170 patients with the disease to healthy people using surveys about body image and emotional distress. The goal was to understand the burden of th…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
AI analyzes 10,000 patient records to predict head and neck cancer recurrence
Knowledge-focused CompletedThis completed study used artificial intelligence to examine electronic health records from 10,000 head and neck cancer patients. The goal was to create models that can predict the risk of cancer coming back or progressing, and to identify which patients might live longer after i…
Sponsor: Savana Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New drug RAB001 takes first step: safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested the safety and tolerability of a new drug called RAB001 in 16 healthy adults. Researchers gave single and multiple injections at two dose levels to see how the body handles the drug and if it causes side effects. This is a first step before testing t…
Phase 1 • Sponsor: ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists hunt for hidden signs in blood cancers to personalize treatment
Knowledge-focused CompletedThis study collected blood, bone marrow, skin, and cheek cell samples from 650 adults with acute leukemia, myelodysplastic syndromes, or myeloproliferative disorders. Researchers analyzed the samples to find genetic, epigenetic, and drug sensitivity patterns that might predict ho…
Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Tiny study probes Tofacitinib's hidden effects on body composition
Knowledge-focused CompletedThis completed study looked at how tofacitinib, a rheumatoid arthritis drug, changes body fat, muscle, and bone density in 10 patients. Researchers measured visceral fat, lean mass, and bone marrow fat before and after treatment. The goal was to gather early data, not to prove th…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
App and wearable track daily struggles of arthritis patients
Knowledge-focused CompletedThis study tested whether a smartphone app and a wearable activity tracker are practical and acceptable for people with inflammatory rheumatic diseases like rheumatoid arthritis and spondyloarthritis. Over 14 days, 50 participants answered short surveys on their phone and wore a …
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists examine bone tissue to uncover causes of hip joint decay
Knowledge-focused CompletedThis study looked at bone tissue from 34 men who had hip replacement surgery due to femoral head necrosis (bone death in the hip joint). Researchers used advanced imaging and spectroscopy to identify changes in bone structure and composition. The goal was to better understand wha…
Sponsor: Lille Catholic University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New tool aims to give older leukemia patients a stronger voice in treatment choices
Knowledge-focused CompletedThis pilot study tested a communication tool called UR-GOAL in 15 older adults (age 60+) with newly diagnosed acute myeloid leukemia (AML), along with their caregivers and doctors. The tool helps patients share their preferences and goals, so treatment decisions better match what…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Nurse detectives: early warning system for arthritis flares?
Knowledge-focused CompletedThis study looked at whether regular nurse check-ins could spot the return of rheumatoid arthritis symptoms sooner than standard doctor visits. 51 adults with controlled arthritis on rituximab took part. The goal was to see if nurses could detect early signs of a flare, potential…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Cuddle cure: skin contact after C-Section boosts breastfeeding and calms nerves
Knowledge-focused CompletedThis study tested whether holding a newborn skin-to-skin right after a C-section (within 5 minutes) or within the first hour helps with breastfeeding, reduces anxiety, and keeps mom and baby healthy. 92 mothers and their newborns took part. The results showed that early contact c…
Sponsor: Çankırı Karatekin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Blood test could predict leukemia survival
Knowledge-focused CompletedThis study tests whether measuring two substances in the blood—FLT3L and IL-6—during chemotherapy can help predict survival in people with acute myeloid leukemia (AML). Researchers will track 201 newly diagnosed AML patients across 25 French hospitals. The goal is to confirm that…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Lupus Patients' Pill-Taking habits under the microscope
Knowledge-focused CompletedThis study looked at how often people with active lupus take their medication as prescribed. Researchers measured blood levels of hydroxychloroquine in 307 patients to find out who was skipping doses. The goal was to understand how common non-adherence is, especially in those wit…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Fertility after fibroid embolization: new data from 46 women
Knowledge-focused CompletedThis study looked back at 46 women who had a procedure called uterine artery embolization to treat fibroids. The goal was to see how often women later had a baby and what pregnancy complications occurred. The researchers reviewed medical records from one hospital in France to gat…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Watchful waiting: new study tracks rare tumor growth without immediate treatment
Knowledge-focused CompletedThis study followed 100 adults with a rare, non-cancerous tumor called peripheral primitive fibromatosis. Instead of treating everyone right away, doctors monitored patients closely to see how the tumors behaved over three years. The goal was to learn which factors might predict …
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
New study tracks hidden heart and bone risks in Cushing's disease
Knowledge-focused CompletedThis study followed 80 people with newly diagnosed Cushing's disease for three years to see how the disease affects the heart, bones, metabolism, and quality of life. Researchers used blood tests, heart scans, bone density tests, and questionnaires to track complications before a…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Can a video call help blood cancer patients prepare for tough decisions?
Knowledge-focused CompletedThis study tested whether a telehealth program could help older patients (60+) with acute myeloid leukemia or myelodysplastic syndrome discuss and document their future medical wishes. Researchers enrolled 36 patients, caregivers, and clinicians to see if the program was easy to …
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Scleroderma hand study reveals key differences in disability
Knowledge-focused CompletedThis study looked at 30 adults with scleroderma, an autoimmune disease that often causes hand stiffness and disability. Researchers measured how much movement was limited in each hand to compare the dominant and non-dominant sides. The goal was to better understand hand function …
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
How many autoimmune patients try alternative therapies? new study counts
Knowledge-focused CompletedThis completed study surveyed 121 adults with autoimmune diseases like lupus, Sjögren's syndrome, or scleroderma. Participants filled out a questionnaire about their use of alternative medicines. The goal was to find out how common these practices are in this patient group.
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Researchers aim to create a universal checklist for scleroderma
Knowledge-focused CompletedThis study aimed to create a standard set of items, called an ICF core set, to describe the health and functioning of people with systemic sclerosis (scleroderma). Researchers gathered input from 100 patients and experts to identify the most important aspects of the disease. The …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Eye scan may forecast vision after brain surgery
Knowledge-focused CompletedThis study tested whether a type of eye scan called OCT-angiography can predict how well vision will recover after surgery to remove a pituitary tumor. Researchers compared the scan results with standard vision tests in 21 patients. The goal was to see if the scan could serve as …
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
5-Year lupus drug safety check: benlysta under the microscope
Knowledge-focused CompletedThis 5-year study tracked over 3,000 adults with active lupus to see how safe and effective Benlysta (belimumab) is compared to standard care alone. Researchers monitored serious infections, cancers, and other side effects. The goal was to gather real-world data to help doctors a…
Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC
-
Coaching teens through the scary leap to adult healthcare
Knowledge-focused CompletedThis pilot study tested whether a transition coach can help 16-17 year olds with Juvenile Idiopathic Arthritis or Inflammatory Bowel Disease move from pediatric to adult care. The coach met with each teen for 8 one-hour sessions covering self-advocacy, medication management, and …
Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Can better scans improve breast cancer bone treatment?
Knowledge-focused CompletedThis study looked at 28 women with breast cancer that spread to their bones. Researchers compared two types of scans—PET-CT and whole-body MRI—to see if they agree on whether the bone tumors are stable, improving, or getting worse. The goal is to find a reliable way to monitor tr…
Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Lupus Patients' quality of life under the microscope in new study
Knowledge-focused CompletedThis study followed 356 adults with lupus over time to see how the disease impacts their quality of life. Participants filled out questionnaires about their symptoms, fatigue, mood, and daily activities. The goal was to better understand what factors affect well-being in lupus, w…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Missing hand muscle may shield against dupuytren disease
Knowledge-focused CompletedThis study compared 243 people with and without Dupuytren disease to see if having the palmaris longus tendon (a small hand tendon not everyone has) is linked to the condition. Researchers used simple hand tests and ultrasound to check for the tendon. The goal is to understand if…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Can a simple test predict who will respond to this sarcoma drug?
Knowledge-focused CompletedThis study aims to find biological markers that can predict whether the drug trabectedin will work in patients with certain types of soft-tissue sarcoma. Researchers will collect tumor biopsies and blood samples from 29 participants before and during treatment. The goal is to use…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Lupus patients get custom steroid tapering plan in new study
Knowledge-focused CompletedThis study tested a personalized way to reduce steroid doses in 72 lupus patients. Doctors used blood tests and regular check-ups over 3 months to safely lower prednisone. The goal was to find the best tapering schedule for each person, minimizing side effects while controlling t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Can better Doctor-Patient talks improve rheumatoid arthritis care?
Knowledge-focused CompletedThis completed study tested whether training rheumatology clinicians in shared decision making helps veterans with rheumatoid arthritis. About 900 patients from VA clinics took part. The training taught doctors to acknowledge treatment options and involve patients in choices. Res…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Marfan Patients' hidden struggles after heart surgery revealed
Knowledge-focused CompletedThis study looked at how heart surgery impacts the mental health, well-being, and quality of life of adults with Marfan Syndrome. Researchers asked 28 patients to fill out questionnaires about depression, fatigue, pain, and self-esteem before surgery and at several points after. …
Sponsor: Barts & The London NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New tool helps patients and doctors choose psoriasis treatments together
Knowledge-focused CompletedThis study aimed to create and test a decision aid for people with psoriasis or psoriatic arthritis who are starting or switching treatments. Researchers worked with 37 patients and their doctors to design a tool that supports shared decision-making. The goal was to help patients…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Scientists test designer immune molecules in autoimmune diseases
Knowledge-focused CompletedThis study looked at whether specially engineered versions of a natural immune protein (IL-2) can selectively boost regulatory T cells, which help calm the immune system. Researchers took blood samples from 67 people with various autoimmune or inflammatory conditions and tested t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
French study tracks Real-World use of oral azacitidine for AML in remission
Knowledge-focused CompletedThis completed study collected real-world data from 112 adults in France with acute myeloid leukemia (AML) who were in remission and taking oral azacitidine as maintenance therapy. The goal was to describe patient characteristics, treatment patterns, and outcomes like relapse and…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Coaching eases tough move to adult rheumatology care
Knowledge-focused CompletedThis study tested whether coaching sessions are practical for young people with rheumatic diseases moving from pediatric to adult care. 26 participants received up to 8 coaching sessions covering self-advocacy, medication management, and future planning. The main goal was to see …
Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Major MDS study tracks 2,115 patients to unlock disease secrets
Knowledge-focused CompletedThis completed study enrolled over 2,100 people with or suspected of having myelodysplastic syndromes (MDS), a group of blood disorders. Researchers collected medical data, blood, and tissue samples over time to track how the disease develops and progresses. The goal was to creat…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Pregnancy's secret signals: could tiny molecules explain arthritis and lupus flares?
Knowledge-focused CompletedThis study looked at how small molecules called microRNAs change during pregnancy in women with rheumatoid arthritis or lupus. Researchers collected blood and urine samples before and after pregnancy from 50 women to see if these changes relate to disease activity. The goal is to…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Leg cancer surgery recovery tracked in new study
Knowledge-focused CompletedThis study followed 100 people who had surgery to remove bone or soft tissue tumors in their leg or pelvis. Researchers measured how independent they became in daily activities and how well their joints moved during the first six months after surgery. The goal was simply to descr…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New study aims to prevent breathing complications after kids' sleep apnea surgery
Knowledge-focused CompletedThis completed study tracked 132 children with obstructive sleep apnea who had their tonsils removed. Researchers recorded how many had breathing problems after surgery, especially those with other health issues. The goal was to create a simple flowchart to help doctors decide wh…
Sponsor: University Hospital, Antwerp • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New test could reveal if arthritis patients are taking their meds
Knowledge-focused CompletedThis study looked at how the drug methotrexate and its main byproduct leave the body in people with rheumatoid arthritis. Researchers measured levels in urine to create a reference range. This could help doctors identify patients who are not taking their medication as prescribed.
Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Lupus kidney clue found in rare antibody?
Knowledge-focused CompletedThis study looked at whether a specific antibody, called anti-GBM, could be a useful marker for lupus nephritis—a serious kidney complication of lupus. Researchers tested stored blood samples from 100 people with lupus (some with kidney issues, some without) and compared them to …
Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Can lowering inflammation protect your heart? new study explores link in arthritis patients
Knowledge-focused CompletedThis study looked at how reducing inflammation might lower heart disease risk in people with rheumatoid arthritis. Researchers measured heart blood flow in 74 patients before and after treatment with certolizumab, a drug that fights inflammation. The goal was to see if better con…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New blood tests could help monitor Flare-Ups in kids with arthritis
Knowledge-focused CompletedThis study measured two newer blood markers (calprotectin and serum amyloid protein) alongside standard tests in 20 children with juvenile arthritis and related conditions. The goal was to see if these markers could better track disease flare-ups in everyday clinic visits. The st…
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New study reveals how fatigue impacts psoriasis and arthritis patients
Knowledge-focused CompletedThis study looked at fatigue in 33 adults with psoriatic arthritis or psoriasis. Researchers used questionnaires to measure tiredness and see how it relates to disease severity and treatments. The goal was to better understand fatigue and its impact on quality of life.
Sponsor: Centre Hospitalier Henri Duffaut - Avignon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Researchers dive into why scleroderma and lung hypertension weaken the heart
Knowledge-focused CompletedThis study looked at 43 adults with scleroderma or unexplained pulmonary arterial hypertension (PAH) to understand why the right side of the heart weakens. Researchers collected blood and tissue samples during routine procedures and measured heart function over 6 months. The goal…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Which donor search strategy saves more lives?
Knowledge-focused CompletedThis study looked at 1,753 patients needing a stem cell transplant for blood cancers or other serious blood disorders. Researchers compared two strategies: first searching for a matched unrelated donor, then trying an alternative donor if needed, versus going straight to an alter…
Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Lupus Pill-Taking habits under the microscope
Knowledge-focused CompletedThis study looked at how faithfully people with lupus take their hydroxychloroquine (Plaquenil). Researchers used a simple questionnaire to measure compliance in 102 patients. The goal was to find which questions best identify those who skip doses, so doctors can catch problems e…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Super MRI scans hand damage in rare disease
Knowledge-focused CompletedThis study used a very powerful 7 Tesla MRI to look at the hands of 50 people with systemic sclerosis (scleroderma), a rare autoimmune disease. The goal was to see bone, joint, and blood vessel problems in detail. Researchers hope this will help them understand how the disease af…
Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Survey reveals why rheumatism patients struggle with Follow-Up care
Knowledge-focused CompletedThis completed study surveyed 229 people with chronic inflammatory rheumatism (like rheumatoid arthritis) and their doctors to find out what makes it hard to follow care recommendations after a hospital visit. The goal was to identify barriers to good outpatient management. No tr…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Blood test for humira levels could personalize arthritis care
Knowledge-focused CompletedThis study looked at 69 adults with rheumatoid arthritis who were taking the drug adalimumab (Humira). Researchers measured drug levels in the blood over 6 months to see if they could predict who would respond well to treatment. The goal was to find a way to adjust doses early, i…
Phase 4 • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Leukemia cells may hide in frozen ovarian tissue, small study warns
Knowledge-focused CompletedThis pilot study looked at ovarian tissue from 9 young women with acute myeloid leukemia who had it frozen to preserve fertility before a stem cell transplant. Researchers checked the frozen tissue for any leftover leukemia cells. The goal was to see if the tissue might be safe t…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Scleroderma mystery: could a simple hormone be involved?
Knowledge-focused CompletedThis study looked at whether people with systemic sclerosis (scleroderma) have higher levels of the hormone prolactin in their blood. Researchers measured prolactin in 71 patients and compared them to healthy volunteers. The goal was to understand if prolactin plays a role in the…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
2,200 patients join global sarcoidosis survey study
Knowledge-focused CompletedThis study collected information from 2,200 people with sarcoidosis around the world using online surveys. The goal was to learn more about how the disease affects different people, not just those seen at major medical centers. Participants also had the option to provide a DNA sa…
Sponsor: Alicia Gerke • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Scientists probe immune Cells' role in skin scarring disease
Knowledge-focused CompletedThis study looked at how B cells, a type of immune cell, may contribute to scarring in people with systemic sclerosis (scleroderma). Researchers compared skin and blood samples from 71 participants, including patients and healthy volunteers. The goal was to understand the disease…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Could white blood cells drive skin scarring in scleroderma?
Knowledge-focused CompletedThis completed study examined whether eosinophils, a type of white blood cell, contribute to fibrosis (scarring) in systemic sclerosis, an autoimmune disease. Researchers compared blood samples from 40 patients with systemic sclerosis and 30 healthy volunteers, with optional skin…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Scleroderma lung study reveals how pneumonia progresses over two years
Knowledge-focused CompletedThis study followed 56 adults with systemic sclerosis (scleroderma) who also had a serious lung complication called diffuse infiltrating pneumonia. Researchers measured lung function at 12 and 24 months to see how it changed and to identify factors that might predict faster decli…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Scientists hunt for lupus genes in kids
Knowledge-focused CompletedThis study looked at genetic and immune system differences in children with lupus, a chronic autoimmune disease. Researchers collected blood samples from 271 participants to search for mutations in known lupus genes and discover new ones. The goal is to better understand what cau…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Laser light may reveal hidden clues in rare skin disease
Knowledge-focused CompletedThis study tested whether a special laser technique called Raman spectroscopy can measure skin fibrosis (hardening) in people with systemic sclerosis, a rare autoimmune disease. Twenty-six adults with the condition had their skin scanned with the laser. The goal was to see if thi…
Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Blood test could tailor leukemia drug dosing
Knowledge-focused CompletedThis pilot study looked at 20 adults with acute myeloid leukemia (AML) who were not healthy enough for strong chemotherapy. They received a standard combination of azacitidine and venetoclax. Researchers measured venetoclax levels in the blood at several time points to see if tho…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Lupus care under the microscope: new study reveals hidden challenges
Knowledge-focused CompletedThis completed study looked at data from 1,000 lupus patients and gathered expert opinions to find where diagnosis and treatment fall short. Researchers reviewed existing information, discussed with doctors, and built consensus on unmet needs. The goal is to publish findings that…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Scientists investigate metabolism in kids with rare genetic syndrome
Knowledge-focused CompletedThis study looked at how children with Noonan syndrome process energy and sugar. Researchers measured insulin sensitivity in 20 children with the condition to see if they have unique metabolic traits. The goal was to better understand the disease, not to test a new treatment.
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Scientists unravel the mystery of menstrual cramps and pain relief
Knowledge-focused CompletedThis study looked at 183 women with menstrual pain to understand why it happens and how naproxen (a common painkiller) relieves it. Using MRI scans, researchers measured uterine activity, blood flow, and oxygen levels before and after taking naproxen or a placebo. The goal is to …
Phase 4 • Sponsor: Endeavor Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Real-World data reveals gaps in bone cancer care
Knowledge-focused CompletedThis study looked back at the medical records of 545 patients with bone tumors that had spread (metastatic). The goal was to see how these patients were treated in real life and what their outcomes were. The study focused on three types of bone tumors: osteosarcoma, Ewing sarcoma…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
38,000 arthritis patients tracked: is abatacept safe Long-Term?
Knowledge-focused CompletedThis completed study looked at the safety of the arthritis drug abatacept in over 38,000 people with rheumatoid or psoriatic arthritis in Denmark. Researchers used a national health registry to track rates of cancers and other side effects. The goal was to better understand the d…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Hidden calcium clues in scleroderma hands and feet
Knowledge-focused CompletedThis completed study involved 214 people with systemic sclerosis (scleroderma) to find out how often calcium deposits form in the hands and feet. Researchers used X-rays to detect these deposits and checked if they were linked to damage in organs like the lungs or heart. The goal…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
PET scans may help guide chemo for rare abdominal cancer
Knowledge-focused CompletedThis study tested whether PET scans can detect early response to chemotherapy in people with retroperitoneal sarcoma, a rare cancer in the abdomen. 18 participants received extra PET scans before and after their first chemo cycle. The goal was to see if PET could predict tumor sh…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Can CRPS patients imagine movement? new study investigates
Knowledge-focused CompletedThis completed study compared how well people with complex regional pain syndrome (CRPS), people with other muscle or bone pain, and healthy individuals can imagine movements. Researchers used a questionnaire called the MIQ-RS to measure motor imagery skills. The goal was to see …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Researchers dig into patient histories to uncover clues about macrophage activation syndrome
Knowledge-focused CompletedThis completed study reviewed the medical charts of 32 people with Still's disease who developed a serious complication called macrophage activation syndrome (MAS). The goal was to learn more about their symptoms, how long it took for lab values to return to normal, and what trea…
Sponsor: Swedish Orphan Biovitrum • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New biobank aims to unlock genetic secrets of rare bone cancer
Knowledge-focused CompletedThis study created a registry and biobank for people with osteosarcoma, a rare bone cancer, and their family members. Researchers collected genetic samples from 362 participants to compare genes of those with and without the disease. The goal is to better understand what causes o…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Virtual reality test reveals hidden memory damage in cured Cushing's patients
Knowledge-focused CompletedThis study looked at whether people who have been cured of Cushing's disease for at least a year still have memory problems. Researchers used a special virtual reality test to check memory, along with standard tests. The goal was to better understand these lasting effects and imp…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New study reveals how long patients stay on secukinumab for skin and joint conditions
Knowledge-focused CompletedThis completed study followed 127 adults with moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, or non-radiographic axial spondyloarthritis who were already taking or starting secukinumab. Researchers observed them for two years to see how long the…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Gut bacteria clues in new arthritis patients
Knowledge-focused CompletedThis study looked at the gut bacteria of 55 people—some newly diagnosed with rheumatoid arthritis and some without the disease. Researchers wanted to see if certain bacteria are more common in arthritis patients. The goal is to better understand how gut health might be linked to …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Personalized dosing for childhood arthritis: study aims to optimize etanercept
Knowledge-focused CompletedThis completed study looked at 126 children with juvenile idiopathic arthritis to find the best dose of the drug etanercept. Researchers measured drug levels in the blood and checked how well the disease was controlled. The goal is to help doctors give each child the right amount…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Researchers track rare hormone disorder in 133 patients
Knowledge-focused CompletedThis study followed 133 people with PPNAD (a rare adrenal gland disorder) or Carney Complex (a related genetic condition) for three years. The goal was to better understand the symptoms and genetic causes of these diseases, not to test a new treatment. Participants had yearly che…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Robot or surgeon? study tests which knee surgery lasts longer
Knowledge-focused CompletedThis study looked at 192 people aged 50-85 with knee arthritis who needed knee replacement surgery. Half had computer-navigated surgery and half had the traditional technique. The goal was to see if computer guidance helps the new knee last longer, improves function, or reduces c…
Sponsor: Haukeland University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Does the flu shot work in sarcoidosis patients? new study aims to find out
Knowledge-focused CompletedThis study looked at whether the seasonal flu vaccine works as well in people with sarcoidosis as it does in healthy people. Researchers gave the flu shot to 190 adults with sarcoidosis and compared their immune response to a group of healthy volunteers. The goal was to see if th…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
AI boosts cancer diagnosis speed in small study
Knowledge-focused CompletedThis study tested whether artificial intelligence (AI) can help doctors diagnose a rare blood cancer called acute promyelocytic leukemia (APL) more quickly and accurately. Ten doctors reviewed bone marrow samples with and without AI assistance. The goal was to see if AI improves …
Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Can we predict who bounces back after a bone marrow transplant?
Knowledge-focused CompletedThis study looked at 126 people aged 60 and older who had a bone marrow transplant for blood cancers like leukemia or lymphoma. Researchers measured physical abilities, mental health, and stress levels before and after transplant to find traits that help people recover better. Th…
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New computer tool aims to help lupus patients choose treatments
Knowledge-focused CompletedThis study tested a computerized decision-aid called SMILE that gives lupus patients information about their disease and treatment options. Nearly 1,900 adults with lupus from multiple clinics used the tool during their visits. The main goal was to see how many eligible patients …
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New tool aims to capture daily life with rare inflammatory diseases
Knowledge-focused CompletedThis study involved 39 adults and children with autoinflammatory diseases like FMF and Still's disease. Researchers conducted interviews to understand how these conditions affect quality of life. The goal was to create a tool that doctors can use to better assess and address pati…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Blood cell counts may reveal clues about autoimmune diseases
Knowledge-focused CompletedThis study looked at specific cells in the blood of 40 women with either Sjögren's syndrome or systemic sclerosis. The goal was to see if counting these cells could help understand the diseases better. No treatment was given; it was purely an observational study to explore potent…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Can a simple questionnaire make virtual rheumatoid arthritis visits better?
Knowledge-focused CompletedThis study tested whether a questionnaire called the Rheumatoid Arthritis Impact of Disease (RAID) could help doctors make better decisions during virtual consultations. 70 patients with rheumatoid arthritis participated. The goal was to see if using this tool reduced the need fo…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:24 UTC
-
Lupus Patients' exercise response under the microscope
Knowledge-focused CompletedThis study looked at how a 12-week program of high-intensity interval training (HIIT) affects fitness and fatigue in 55 people with lupus. Researchers wanted to understand if certain immune system signals (interferons) change how the body adapts to exercise. Participants were ran…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:24 UTC